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Abstract 
Background 
Most couples enrolled in Assisted Reproductive Technologies’ (ART) treatments need to make 
decisions regarding embryo disposition, as they are asked to sign a consent form concerning 
embryo donation for research. Decision-making on embryo donation for research is influenced by 
three main iterative and dynamic dimensions: (i) hierarchisation of the possible options regarding 
embryo disposition, framed on patients’ beliefs about what should be done or their 
representations regarding the moral and social status of embryos; (ii) patients’ understanding of 
expectations and risks of the research on human embryos; (iii) and patients’ experiences of 
information exchange and levels of trust in the medical-scientific institutions. Results relating to 
the influence of sociodemographic characteristics and reproductive and gynaecological history 
were mostly inconclusive (PAPER I).  
In the context of clinical practices involving informed consent on embryo disposition, it is crucial 
to ground legal and regulatory frameworks on patients’ values, preferences, choices and 
expressed needs to lend credence and robustness to the consent that the couples give. Further 
research on patients’ experiences and perspectives about the healthcare system, and on the 
human factors involved in the decision-making process regarding embryo donation for research, 
is needed to contribute to the implementation of informed relational ethics in clinical practice and 
to improve patient-centredness in the field of ART at three main levels. First, the circumstances 
under which the informed consent should be delivered, explained and signed, considering that 
patients’ attitudes about embryo disposition evolve over time; second, the sociodemographic, 
reproductive and psychosocial characteristics and reasons associated with willingness to donate 
embryos for research; lastly, the perceptions about storage limit for embryos, taking into account 
that they may shape decision-making on embryo disposition and that there is no evidence 
justifying the current storage periods.  
Objectives 
To produce evidence to sustain the development of patient-centredness regarding embryo 
donation for research. To accomplish this aim, four studies were performed, with the following 
specific objectives: 
1) To assess the psychosocial, demographic and reproductive factors and socioethical reasons 
associated with willingness to donate embryos for research among IVF couples. 
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2) To analyse IVF couple’s willingness to donate cryopreserved embryos for over time, taking into 
account the influence of psychosocial, demographic and reproductive factors. 
3) To assess IVF patients’ opinions about the storage limit for embryos and to explore their 
perceptions of the criteria underlying the establishment of the storage period offered to them.  
4) To analyse the perceptions of IVF couples regarding the factors that contextualize informed 
consent regarding embryo cryopreservation. 
Methods 
This is an observational and longitudinal mixed-methods study. The methodological strategy 
relied on three evaluation moments: (1) quantitative questionnaire with couples in IVF/ICSI 
treatments, over 12 consecutive months (baseline); (2) semi-structured interviews to a subsample 
of couples, conducted 3 months after baseline; (3) quantitative questionnaires 12 months after 
baseline. Between August 2011 and August 2012, 221 heterosexual couples and 92 women 
undergoing IVF were systematically recruited in a Portuguese public fertility centre (participation 
rate=95.1%). Data on sociodemographic characteristics, reproductive history, psychosocial 
variables, willingness and reasons to donate embryos for research were collected by self-report 
questionnaires. No statistically significant differences were found in the self-reporting of 
depression, anxiety, social support and partner relationship or in sociodemographic and obstetric 
characteristics between women interviewed alone or with the partner (PAPER II). Approximately 
three months after completing the questionnaire, semi-structured interviews with 34 couples took 
place between March and December 2012. About 12 months after completing the quantitative 
questionnaire applied at baseline, all the participants who previously agreed to be invited to 
participate in the third phase of the study were contacted. Those who agreed to be included in 
the 12-months after evaluation were sent the self-administered part of the questionnaire by mail. 
At this moment, 221 participants (114 women and 107 men) returned the questionnaires 
(participation rate=41.4%), in a total of 104 couples. 
Descriptive and inferential statistics were used to analyse the quantitative data. In qualitative data, 
content analysis protocols, with an iterative and reflexive process, were implemented according to 
the objectives of each paper. 
Results 
The majority of the 213 couples who had information on the outcome variable was willing to 
donate embryos for research (87.3%; 95%CI: 82.1-91.5), expecting benefits for science, health and 
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infertile patients. Almost all couples reached consensus regarding the decision (94.3%; 95% CI: 
89.8-96.7). Willingness to donate was more frequent among women below 36 years old (OR=3.06; 
95%CI: 1.23-7.61) and who considered embryo research to be very important (OR=6.32; 95%CI: 
1.85-21.64); and in Catholic men (OR=4.16; 95%CI: 1.53-11.30). Those who were unwilling to 
donate reported the conceptualization of embryos as children/lives, lack of information or fears 
about embryo research to justify their decision. Men with higher levels of trait anxiety (OR=0.90; 
95%CI: 0.84-0.96) were less frequently willing to donate (PAPER III). 
Over time, a significant decrease in patients’ willingness to donate embryos for research was 
registered (86.5% to 73.6%; RR= 0.85; 95% CI: 0.76-0.95). Participants with more than 12 years of 
education and who considered research with human embryos to be important (vs very important) 
were less frequently willing to donate embryos for research over time (RRinteraction= 0.77; 95% CI: 
0.63-0.95 and RRinteraction= 0.70; 95% CI: 0.50-0.98, respectively) (PAPER IV).  
In this sample of women and men undergoing IVF, 38% of participants preferred the duration of 
4-5 years for embryo storage limit, 38% extended it beyond 5 years and 23% indicated 3 years. 
Having experienced at least one previous cycle was directly associated with agreeing with a 
duration of storage longer than 5 years, for both women and men (OR=2.94; 95% CI: 1.51–5.71 
and OR=2.44; 95% CI; 1.17–5.08, respectively). Having children was inversely associated with 
longer duration of storage, among women. One third of the 34 interviewed couples stated that 
their knowledge concerning embryo storage was insufficient. Nevertheless, all the interviewees 
reported at least one possible reason for the legal establishment of the storage period offered to 
them, highlighting financial costs and decreased embryo quality. There were misconceptions and 
gaps in awareness of cryopreservation which may shape patients’ opinions (PAPER V). 
Data gathered through the 34 semi-structured interviews revealed a perception of informed 
consent as a formality, signed in an inadequate period of time and often administered by non-
qualified professionals. The following needs have been identified: timely provision of detailed, 
accurate and intelligible information about the costs of cryopreservation, embryo storage limit 
and effective options for embryo disposition; reinforcement of physical privacy; availability of time 
to reflect about embryo disposition and the disclosure of users’ identities (PAPER VI). 
Conclusion  
This thesis provided evidence to sustain the development of patient-centredness on embryo 
donation for research, with implications for clinical practice and regulation. Looking at patient-
centred care through the lens of public health, this study contributes to advance knowledge in 
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three key areas: openness and information about research with human embryos; suitability of 
research projects using cryopreserved embryos; policies and guidelines regarding informed 
consent process on embryo donation for research. Data provided by this study was also important 
to deconstruct ideas regarding the influence of being Catholic on embryo donation for research. 
Its innovativeness also relies on the assessment of psychosocial variables as anxiety, depression 
and quality of partner relationship, and the inclusion of both members of the couple, considering 
that these methodological features are absent from most of the studies on embryo disposition. 
Achievements from this study revealed a high receptivity to scientific and technological progress 
and trust in medical institutions and their professionals. Lack of information and gaps and 
misconceptions reported by patients highlighted that attention should be drawn to the 
responsibility of scientific and medical institutions, health professionals and researchers regarding 
the provision of accurate and timely information that is attentive, responsive, and tailored to 
patients’ needs. The communication of realistic expectations as well as discussions about the risks 
and limitations of research with human embryos should be central topics in the ethics of clinical 
research, care and doctor-patient relationships centred on patients. 
Lastly, this study calls on the one side for the inclusion of the subject of decision-making on 
embryo disposition in general guidelines for psychosocial care in infertility and ART, and, on the 
other side, to the need to improve clinical practices involving informed consent in order to make 
them more patient-centred. Our achievements may help to inform ethical debates on the 
credence and robustness of informed consent given by couples and on the circumstances under 
which the informed consent should be delivered, explained and signed, including the 
establishment of storage periods and the reasons for limitations in these periods. 
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Resumo 
Introdução  
A maioria dos casais envolvidos em técnicas de Procriação Medicamente Assistida (PMA) são 
confrontados com a necessidade de tomar uma decisão quanto ao destino dos embriões 
criopreservados, sendo-lhes solicitada a assinatura de um consentimento informado sobre a 
doação de embriões para investigação. Esta decisão é influenciada por três dimensões dinâmicas 
e iterativas: (i) hierarquização das opções possíveis para o destino dos embriões, enquadrada nas 
crenças dos pacientes acerca do que deve ser feito e nas suas representações acerca do estatuto 
moral e social dos embriões; (ii) forma como os pacientes compreendem as expectativas e os 
riscos associados à investigação com embriões de origem humana; (iii) experiências dos pacientes 
a nível da informação e respetivos níveis de confiança nas instituições médico-científicas. 
Globalmente, os resultados sobre a influência das características sociodemográficas, reprodutivas 
e da história ginecológica são inconclusivos (ARTIGO 1). 
No âmbito das práticas clínicas que envolvem o consentimento informado na criopreservação, é 
crucial que os enquadramentos legais e regulatórios se enraízem nos valores, preferências, 
escolhas e necessidades expressas pelos pacientes, de forma a conferir credibilidade e robustez 
ao consentimento. Neste contexto, conhecer as experiências e perspetivas dos pacientes quanto 
aos fatores humanos e do sistema de saúde que estão envolvidos no processo de decisão em 
relação à doação de embriões para investigação científica é fundamental para informar a ética 
relacional na prática clínica e para melhorar a prestação de cuidados centrados no paciente no 
contexto da PMA, principalmente a três níveis. Em primeiro lugar, as circunstâncias em que o 
consentimento deve ser entregue, explicado e assinado, considerando que as atitudes quanto à 
doação de embriões para investigação evoluem ao longo do tempo; em segundo lugar, as 
características sociodemográficas, reprodutivas e psicossociais e as razões associadas à doação de 
embriões para investigação científica; e, por fim, as perceções acerca do período máximo de 
criopreservação, aspeto que pode influenciar a decisão, e cuja delimitação não assenta em 
evidência científica. 
Objetivos 
Produzir conhecimento que sustente o desenvolvimento de práticas de saúde centradas no 
paciente quanto à doação de embriões para investigação. Neste sentido, foram realizados quatro 
estudos com os seguintes objetivos específicos: 
1) Avaliar os fatores psicossociais, demográficos e reprodutivos, bem como as razões associadas à 
doação de embriões para investigação em casais envolvidos em FIV.  
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2) Analisar as atitudes dos casais em FIV quanto à doação de embriões para investigação, ao 
longo do tempo, tendo em conta a influência de fatores psicossociais, demográficos e 
reprodutivos. 
3) Explorar as opiniões dos pacientes sobre o período máximo de criopreservação de embriões e 
as suas perceções acerca dos critérios subjacentes ao estabelecimento do limite de 
criopreservação que lhes é oferecido. 
4) Analisar as perceções de casais em FIV sobre o consentimento informado para a 
criopreservação de embriões. 
Métodos 
Com base numa metodologia mista, este estudo observacional e longitudinal incluiu três 
momentos de avaliação: (1) questionário quantitativo com casais envolvidos em fertilização in 
vitro e injeção intracitoplasmática de espermatozoides, durante 12 meses consecutivos; (2) 
entrevistas semiestruturadas a uma subamostra de casais, realizadas 3 meses após o primeiro 
momento de avaliação; (3) reavaliação 12 meses após o contacto inicial, com questionários 
quantitativos. Entre agosto de 2011 e agosto de 2012, 221 casais heterossexuais e 92 mulheres 
envolvidos em fertilização in vitro e injeção intracitoplasmática de espermatozoides foram 
recrutados sistematicamente numa Unidade Pública de Medicina da Reprodução (proporção de 
participação=95,1%). Recolheram-se dados sociodemográficos e da história reprodutiva; dados 
psicossociais; e atitude e razões quanto à doação de embriões para investigação, através de 
questionários. Não se encontraram diferenças estatisticamente significativas no reporte de 
depressão, ansiedade, suporte social e relação com o parceiro, ou nos dados sociodemográficos e 
obstétricos, entre as mulheres que foram entrevistadas sozinhas ou com o parceiro (ARTIGO II). 
Aproximadamente três meses após o preenchimento do questionário, realizaram-se 34 entrevistas 
semiestruturadas em casal, entre março e dezembro de 2012. Cerca de 12 meses após o primeiro 
momento de avaliação, todos os participantes que aceitaram continuar no estudo foram 
contactados. Entre estes, os que concordaram em participar na reavaliação receberam por correio 
o mesmo questionário autoadministrado que tinham preenchido no primeiro momento, bem 
como os consentimentos informados, com um envelope para devolução. Devolveram os 
questionários 221 participantes (114 mulheres e 107 homens), num total de 104 casais (proporção 
de participação=41,4%). Foi utilizada estatística descritiva e inferencial para analisar os dados 
quantitativos. Os protocolos de análise de conteúdo de dados qualitativos foram escolhidos de 
acordo os objetivos de cada estudo, num processo reflexivo e iterativo. 
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Resultados 
A maioria dos 213 casais com dados sobre a atitude quanto ao destino dos embriões 
criopreservados aceitou doar embriões para investigação (87,3%; IC95%: 82,1-91,5), referindo os 
benefícios esperados para a ciência, a saúde e os casais inférteis. A grande maioria dos casais 
chegou a consenso quanto à decisão tomada (94,3%; IC95%: 89,8-96,7). A doação de embriões 
para investigação foi mais frequente em homens católicos (OR=4,16; IC95%: 1,53-11,30) e em 
mulheres com menos de 36 anos (OR=3,06; IC95%: 1,23-7,61) e que atribuíram muita importância 
à investigação com embriões (OR=6,32; IC95%: 1,85-21,64). Aqueles que não aceitaram doar 
reportaram mais frequentemente falta de informação ou receios acerca da investigação com 
embriões e conceptualizaram o embrião como criança/ser vivo. Os homens com níveis mais 
elevados de ansiedade-traço (OR=0,90; IC95%: 0,84-0,96) tenderam a não doar (ARTIGO III). 
Uma análise da evolução da atitude quanto à doação de embriões para investigação, ao longo do 
tempo, mostrou uma descida significativa na tendência para doar (86,5% a 73,6%; RR= 0,85; 
IC95%: 0,76-0,95). Os pacientes mais escolarizados (> 12 anos de escolaridade) e que 
consideraram importante a investigação com embriões (por comparação com os que 
consideraram muito importante) doaram menos para investigação no segundo momento 
(RRinteração= 0,77; IC95%: 0,63-0,95 e RRinteração= 0,70; IC95%: 0,50-0,98, respetivamente) (ARTIGO 
IV).  
O estudo das opiniões dos pacientes acerca do limite máximo da criopreservação de embriões 
revelou que 38% dos participantes defenderam a extensão do limite para 4-5 anos e 38% 
defenderam a extensão para além dos 5 anos, sendo que 23% defenderam o atual limite legal de 
3 anos. Os participantes que realizaram pelo menos um tratamento referiram, mais 
frequentemente, um período máximo de criopreservação superior a 5 anos (OR=2,94; IC95%: 
1,51–5,71 e OR=2,44; IC95%; 1,17–5,08, em mulheres e homens, respetivamente). Ter filhos 
associou-se inversamente à preferência por longos períodos de criopreservação, entre as 
mulheres. Um terço dos 34 casais entrevistados referiram ter um conhecimento escasso sobre os 
critérios usados para estabelecer um limite temporal na criopreservação de embriões. No entanto, 
todos os entrevistados reportaram pelo menos uma razão possível para o estabelecimento legal 
do limite máximo que lhes é oferecido, salientando os custos da criopreservação e a diminuição 
da qualidade dos embriões. Encontraram-se conceções erradas e lacunas no conhecimento sobre 
criopreservação de embriões, aspetos que podem moldar as opiniões dos pacientes (ARTIGO V). 
Os dados obtidos através das 34 entrevistas semiestruturadas revelaram que o consentimento é 
percecionado como um formalismo, é assinado num momento inadequado e muitas vezes 
aplicado por profissionais não qualificados. Emergiram as seguintes necessidades: provisão 
atempada de informações detalhadas e coerentes sobre os custos e duração da criopreservação e 
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o destino dos embriões; reforço da privacidade física; tempo para refletir sobre o destino dos 
embriões e sobre a divulgação da identidade dos beneficiários (ARTIGO VI). 
Conclusão  
Esta tese gerou conhecimento que sustenta o desenvolvimento de políticas e cuidados centrados 
no paciente no âmbito da doação de embriões para investigação, com implicações para a prática 
clínica e a regulação. Perspetivando os cuidados centrados no paciente do ponto de vista da 
saúde pública, este estudo contribui para o avanço do conhecimento em três áreas principais: 
recetividade à doação e informação sobre a investigação em embriões; adequação dos projetos 
de investigação com embriões de origem humana às perspetivas dos casais; políticas e 
orientações para o processo de consentimento informado na criopreservação. Os resultados 
obtidos foram ainda importantes para a desconstrução de ideias acerca da influência da crença na 
religião Católica na doação de embriões para investigação. O caráter inovador deste trabalho 
apoia-se também na avaliação de variáveis psicossociais como ansiedade, depressão e qualidade 
da relação conjugal, incluindo ambos os membros do casal, num contexto em que estas 
componentes metodológicas estão ausentes da maioria dos estudos que avaliam os fatores 
associados à doação de embriões para investigação.  
Este estudo revelou uma recetividade elevada ao progresso científico e tecnológico e confiança 
nas instituições e profissionais de saúde. O facto de os pacientes reportarem falta de informação e 
conceções erradas sobre a criopreservação e a investigação em embriões humanos alerta para a 
responsabilidade das instituições científicas e médicas, dos profissionais de saúde e dos 
investigadores quanto à prestação de informação adequada e oportuna, que seja responsiva e 
adaptada às necessidades dos pacientes. A comunicação de expectativas realistas e a discussão 
dos riscos e limitações da investigação com embriões devem ser tópicos centrais da ética na 
investigação e nos cuidados de saúde centrados no paciente. 
Por fim, este estudo apela, por um lado, à inclusão deste tópico nas diretrizes para o cuidado 
psicossocial em infertilidade e PMA e, por outro, à necessidade de melhorias nas práticas clínicas 
que envolvem o consentimento informado, de forma a torná-lo mais centrado no paciente. Os 
dados deste estudo contribuem para informar os debates éticos sobre a credibilidade e robustez 
do consentimento informado, bem como as circunstâncias em que o mesmo deve ser entregue, 
explicado e assinado, incluindo a definição do limite máximo de tempo para a criopreservação e 
as razões subjacentes. 
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The introductory chapter of this thesis aims to provide a comprehensive overview of the 
psychosocial, clinical, regulatory and legal frameworks where embryo donation for research 
occurs. It is argued that further research on patients’ experiences and perspectives about the 
healthcare and regulatory systems, and on the human factors involved in the decision-making 
process regarding embryo donation for research, is needed to contribute to the implementation 
of informed relational ethics in clinical practice and to improve patient-centredness in the field of 
ART.  
The first section briefly summarizes the quantitative indicators about the prevalence of infertility 
and the number of ART cycles, advocating the need to devote more attention to psychosocial, 
ethical and relational issues of involuntary childlessness in public health research on infertility in a 
context where an increasing number of embryos has been storage.  
The second section presents the contours of a responsible governance of human embryo research 
in a scenario characterized by differences in national and transnational laws and policies regarding 
the use of human embryonic stem cells in research and the maximum length for embryo storage, 
and uncertainties on whether the informed consent should be signed by IVF patients prior to the 
first treatment, during treatment or after treatment is completed, detailing the Portuguese legal 
and regulatory landscape that frames the present work. Research needs to find a balance between 
expectations and controversies, empirically grounded on the assessment of the moral and ethical 
spectrum involving both scientists and stakeholders and the public, in particular those people who 
must make embryo disposition decisions, whose perspectives and experiences are a core need for 
patient-centred care and policies on human embryo research. 
The last section explores the theoretical, methodological and pragmatic challenges raised by the 
conceptualization and implementation of patient-centredness on infertility and ART, calling for a 
renewed debate that includes the subject of decision-making on embryo disposition, namely 
embryo donation for research, and looks at patient-centredness through the lens of public health. 
Knowledge on patient’s perspectives and experiences with regard to embryo donation for 
research is essential for the conceptualization of patient-centred policies and for ethics in clinical 
practice at the following levels: to analyse openness and information about research with human 
embryos; to sustain stakeholders’ decisions regarding the suitability of research projects using 
cryopreserved embryos; and to disseminate ethically robust evidence to inform policies and 
guidelines on embryo cryopreservation and embryo disposition. 
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1.1 Infertility and Assisted Reproductive Technologies 
1.1.1 Definition and prevalence 
According to the World Health Organization (WHO) and the International Committee for 
Monitoring Assisted Reproductive Technology (ICMART)a, infertility is considered “a disease of the 
reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or 
more of regular unprotected sexual intercourse”1. In 2013, the American Society for Reproductive 
Medicine (ASRM) proposed to include in such definition the cases where the failure to achieve a 
clinical pregnancy occurs after therapeutic donor insemination2. In addition, recent guidelines 
have shortened the period of 12 months to 6 months of unprotected sexual intercourse without 
achieving a pregnancy when there is a medical history and physical evidence, previously known to 
potentially compromise fertility (e.g., cancer patients; in women, oligomenorrhea, amenorrhea, 
advanced stage endometriosis), or when women are aged above 35 years3.  
Despite the definition previously presented, there are differences regarding the threshold 
considered in the diagnosis of infertility when comparing clinical and epidemiological studies: 
while 1 year has become the gold standard for clinical purposes1, epidemiological studies use a 
time horizon of 5 years, “in order to reduce the likelihood of misclassifying fertile unions as 
infertile”4. In fact, there is no biological basis for the establishment of 1 year of regular 
unprotected sexual intercourse as a clinical criterion for the diagnosis of infertility, since a 
considerable proportion of spontaneous pregnancies occurring after the first 12 months of trying 
is observed. Besides the time threshold, the present definition of infertility includes an ambiguous 
criterion - the “regular” intercourse, in the sense that it does not adequately account for how time 
and frequency of sexual intercourse may influence conception and the quality of gametes5, 6, 
which claims for more attention to psychosocial and relational aspects of involuntary 
childlessness. 
While in females, the common biological causes of infertility are ovulatory dysfunction, ovarian 
abnormalities, abnormalities of cervical mucus production or sperm/mucus interaction and 
abnormalities of uterine anatomy or function and endometriosis3, in males, the reduction in the 
number of sperm (oligospermia), low sperm motility (asthenoteratospermia); sperm with abnormal 
                                                 
aThe International Committee Monitoring Assisted Reproductive Technologies (ICMART) is an independent, international 
non-profit organization that has taken a leading role in the development, collection and dissemination of worldwide data 
on Assisted Reproductive Technologies (ART). It is supported by the following organizations: American Society for 
Reproductive Medicine (ASRM), Society for Assisted Reproductive Technology (SART), European Society for Human 
Reproduction and Embryology (ESHRE), Latin American Network for Assisted Reproduction (REDLARA), Fertility Society of 
Australia (FSA), Japan Society for Reproductive Medicine (JSRM), and Bertarelli Foundation. 
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morphology (teratospermia); absence of a measurable level of sperm in semen (azoospermia) or 
inability for vaginal ejaculation are the established causes7. 
According to the cause of infertility, clinical subtypes are commonly defined as due to a male 
factor (40% of cases), female factor (40%), couple factor (10%) or unknown factor (10%)8, 9. 
However, these estimates vary across studies, being influenced by physician’s practices, 
extensiveness of clinical testing and their sensitivity and specificity, and the limited information 
about what constitutes normal variations in human fecundity9. Previous studies have shown 
variations of infertility from an unknown factor ranging from 15 to 30%10, with women over 35 
years of age having the double probability to present unexplained infertility11. When the cause of 
infertility is unexplained, the probability of achieving a spontaneous pregnancy seems to be 
higher among younger women and who performed a smaller number of In Vitro Fertilization (IVF) 
attempts12. 
Infertility is currently seen as a global public health issue13, considering the challenges imposed by 
declining fertility rates on population renewal in various developed countries for the last century14 
and the promotion of universal access to sexual and reproductive health in the context of the 
primary healthcare approach15. Arguments as a decline in sperm concentration and quality over 
time9, 16, 17, secular events such as changes in the availability of contraception and new legislation 
about abortion18, economic factors affecting education, employment and family life19, or changes 
in the attitudes and cultural values of men and women20 have been pointed out to justify the 
decline in fertility and number of births. Research has also focused on the influence of 
environmental exposures, as toxins, pesticides and other pollutants, on fertility17, 21, 22. A recent 
study has found that higher levels of stress as measured by salivary alpha-amylase are associated 
with a longer time-to-pregnancy and an increased risk of infertility23. An increase in the incidence 
of age-related subfertility in women and, to a lesser extent in men, is associated with delaying the 
birth of the first child24. However, the question of a possible decline in human capacity to conceive 
remains unanswered16, being important to continue studying the interactions between 
reproductive capacity and social changes14. 
A main challenge in this field is related to the estimation of infertility prevalence rates. Population-
based studies are scarce and the few high-quality studies available used inconsistent definitions, 
with different numerators and denominators4, 25. In order to overcome these difficulties and 
synthesize data on the prevalence of infertility, a systematic review with 277 demographic and 
reproductive health surveys was performed applying a consistent algorithm to measure infertility 
using household survey data26. Global trends in infertility prevalence (both primary and secondary) 
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were estimated in the absolute number of 48.5 million (95% confidence interval (95% CI): 45.0-
52.6) infertile couples. Primary infertility prevalenceb among child-seeking women varied by region 
in 2010, from 1.5% (95%CI: 1.2%, 1.8%) in the Latin America/Caribbean region, to 2.6% (95% CI: 
2.1%, 3.1%) in the North Africa/Middle East region. Twenty-year trends in infertility prevalence 
were not statistically significant in most regions26. In Portugal, a study with the EPIPorto cohort 
estimated a lifetime infertility prevalence of 11.9% (95% CI: 10.4%-13.7%)27c. 
While primary infertility is mainly registered in high income countries, low income countries 
present higher rates of secondary infertility (inability to conceive among couples with a previous 
pregnancy, regardless of outcome), mostly due to untreated or poorly managed reproductive 
tract infections, including sexually transmitted infections, and also because infertility is deemed a 
low-priority issue in the context of scarce healthcare resources15, 28. For example, in the Arab Gulf 
and South Asia, a new “infertility epidemic is raging”, which is linked to overweight/obesity, insulin 
resistance/diabetes and polycystic ovary syndrome (PCOS), the global solution of which is still 
obscure28.  
In the last decades, there is a focus on high-tech treatments or procedures that include the in vitro 
handling of both human oocytes and sperm, or embryos, for the purpose of establishing a 
pregnancy – the Assisted Reproductive Technologies (ART)1, as the preferable option to deal with 
infertility29. Although ART should not jeopardize the acknowledgement of the importance of 
prevention and lower tech solutions, as well as the awareness about adoption or foster care, or 
the cessation of treatment and the acceptance of infertility30-32, the use of ART seems to have 
increased in the last years in Europe. In 1997, 203 893 ART cycles (including intrauterine 
insemination) were registered, being 1183 of these recorded in Portugal33, while in 2010, a total of 
550 296 ART cycles were performed in Europe, and 7179 cycles in Portugal34d. The proportion of 
children conceived through ART per national births has also increased in the two last decades, 
among the countries providing data to the European Society of Human Reproduction and 
Embryology (ESHRE), ranging from 1.0% in Switzerland to 3.5% in Iceland, in 199733 and from 0.6% 
in Moldova to 5.9% in Denmark, in 201034. In Portugal, the proportion raised from 1.2% in 200735 
                                                 
b Primary infertility was defined as the absence of a live birth for women who desire a child and have been in a union for at 
least five years, during which they have not used any contraceptives. The prevalence of primary infertility was calculated as 
the number of women in an infertile union divided by the number of women in both infertile and fertile unions, where 
women in a fertile union have successfully had at least one live birth and have been in the union for at least five years at 
the time of the survey. 
c In this study, primary infertility was defined as the absence of pregnancy after a year trying to get pregnant, in a women 
who was never pregnant (or who were more than one year trying to get pregnant before the first pregnancy). 
d It is important to note that these values may lead to a biased interpretation, due to the fact that between 1997 and 2010 
a huge investment in monitoring and quality control was observed in infertility care, forcing the registration of cycles. Thus, 
the number of cycles performed in 1997 may have been under-registered.  
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to 1.9% in 201034e. Among the total number of ART treatment cycles performed in Europe in 2010, 
approximately 20% (n=114 593) resulted from frozen embryo replacement. In Portugal, in the 
same year, the proportion of ART treatment cycles with frozen embryo replacement was 12.8% 
(n=921)34.   
Besides infertile couples, ART treatments also involve people who are seeking for prevention of 
transmission of genetic or infectious diseases through Preimplantation Genetic Diagnosis (PGD)34f. 
This is the case of carriers of genetic diseases or individuals chronically infected with HIV or 
hepatitis C virus, as these individuals can transmit the genetic disease or infection to their 
offspring or to an uninfected partner during the process of conception, in the case of 
communicable diseases.  
1.1.2 Psychosocial issues 
The importance of developing evidence-based guidelines for psychosocial care in ART treatments 
has been recently recognized by the ESHRE and the ASRM36, 37. This call for high-quality 
psychosocial care is based on evidence about the benefits of counselling to reduce stress and 
concerns about medical procedures38, 39, to improve lifestyle outcomes40 and patient well-being41, 
42, and compliance with treatment43. However, the psychosocial burden of ART and infertility goes 
beyond these dimensions, and includes feelings of result self-blame and guilt, fear, economic 
hardship due to treatment costs, social isolation, loss of social support, divorce and social 
stigma30, 32, 44, 45. 
Also, some patients discontinue treatment without achieving a live birth because of the physical 
and psychological burden of treatment, relational and personal problems, treatment rejection and 
organizational and clinic problems (as language problems; therapeutic programme difficult to 
integrate with work; insufficient or poorly formulated explanations about healthcare or fertility 
problem; poor management of psychological aspects) and also due to poor prognosis to achieve 
a pregnancy (based on the older age of women, problems with semen quality or the menstrual 
cycle, for example)36, 46, 47. 
The burden of infertility and ART is worsened in contexts where childbearing is a societal and 
cultural imperative48. In fact, different meanings attributed to infertility and to gender roles have 
                                                 
e It is important to note that the number of clinics reporting data to ESHRE, in Portugal, increased from 22, in 200735, to 25, 
in 201034. 
f The “analysis of polar bodies, blastomeres or trophectoderm from oocytes, zygotes or embryos for the detection of 
specific genetic, structural and/or chromosomal alterations” before embryo transfer. 
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implications on how individuals deal with this health condition31, 49: some couples experienced 
infertility as a life-crisis that brought them together and strengthened their relationship41, 50, while 
other couples often cited difficulties in the partner relationship30, 51.  
At the same time, experience of infertility is socially determined: patients with a low occupational 
status experience higher infertility stress and anxiety than patients with a medium or high 
occupational status52; and patients with lower education level may take more treatment-related 
hours off work53, with harder consequence to the familial resources. 
Different socioeconomic, cultural and political contexts also underlie searching for cross-border 
reproductive care (CBRC), often referred to as ‘reproductive tourism’54, ‘reproductive exile’55, 56 or 
‘transnational reproduction’57. The main reasons underlying the movement of persons from one 
jurisdiction to another in order to access or provide ART may be grouped into four broad 
categories: 1) law evasion - avoidance of legal, religious, and ethical restrictions and regulations 
from a departure country; 2) the access to more resources, including shorter waiting lists or lower 
costs of treatment; 3) the search for more extensive higher quality of care and safety concerns; 
and 4) personal preferences or privacy58-61. 
Involving patients at the intersection of medicine, law, business and travel58, CBRC presents two 
main challenges for public health: the need to protect patients from poor quality and unsafe 
services abroad; the need to protect disadvantaged individuals from being exploited for their 
reproductive tissues or capabilities62, 63 and to prevent the exploitation of existing global 
inequalities and hierarchies in the service of new reproductive technologies64. More specifically, an 
international surveillance system65 and a system of certification of centres may be developed, 
considering equity, safety, efficiency, effectiveness (including evidence-based care), timeliness and 
patient-centredness66 at the following dimensions: preventing the transmission of infectious 
diseases or genetic disorders; provision of understandable information and  adequate translation 
of informed consent; avoidance of lack of medical records; provision of legal advice in the event of 
patient harm abroad; and provision of best-practice psychosocial counselling support and 
development of counselling guidelines60, 61, 67. At the same time, host countries may witness an 
increase in the costs of some services or they can be of harder access for local patients61, while a 
decrease on the pressure for law reform internally may occur in home countries59. 
This is particularly relevant in a context where all phases of treatment require psychosocial care in 
response to specific needs36. In fact, it is now widely recognized that many IVF patients find it 
difficult to manage the usually lengthy diagnostic and treatment period, and the uncertainty of 
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achieving parenthood68, while experiencing some degree of emotional distress during treatment69. 
Several moments had been identified as the most stressful: oocyte retrieval, the waiting period for 
the pregnancy test, the day of a negative pregnancy result and after a miscarriage70, 71. 
At the ‘pre-treatment’ period, that begins at the first visit to the clinic up to the start of the first 
treatment cycle, previous research showed that patients are not more depressed than the general 
population or matched controls, while data concerning anxiety is inconsistent when comparing 
IVF patients with the general population36. In both women and men, unexplained infertility seems 
to be harder to cope with than when a cause is identified69. 
Stress during treatment has been described as multi-dimensional69, being connected to three 
main aspects: chronic stress caused by the threat of infertility and the loss of hope; stress from the 
prospect treatment; and the stress of the actual enrolment in the treatment with its daily 
injections, scans and invasive proceduresg72. About one-third of patients did not achieve 
pregnancy or a live birth within 5 years of the start of treatment73 and many experience difficulties 
adjusting to their unmet parenthood goals74. The relatively low chance of success is one of the 
greatest restraints of ART75h, being women and men at high risk for major depressive disorder 
during the course of unsuccessful treatments76. Anxiety and stress are also higher when patients 
are anticipating results and they experience high emotional distress when they are informed that 
the treatment was unsuccessful36.  
While involving the couple, the fact that most medical procedures in ART occur on women’s 
bodiesi represents an additional burden for women, who tended to experience a disciplinary 
regime based on individual responsibility for the maximization of the probability of a successful 
treatment6. The medical and scientific recognition of limitations, uncertainties and risks is an 
                                                 
g These procedures may, in some cases, lead to biological complications. This is the case of ovarian stimulation that is the 
use of medications, oral or injectable, for hormonal manipulation to enhance ovulation during the ovulatory cycle so that 
the ovary is stimulated to release multiple oocytes, instead of one8, 78. Although this process increases the chance of 
getting a higher number of eggs to fertilize, it also implies the risk to induce an excessive reaction of the ovaries, which 
become swollen and painful - ovarian hyperstimulation syndrome (OHSS)1. The OHSS is a serious complication of 
induction of ovulation, which can lead to hospitalizations, due to rapid weight gain and abdominal pain, vomiting or lack 
of appetite, among other symptoms1, 77. According to the last report of the European Society of Human Reproduction and 
Embryology, 1500 cases of OHSS were recorded in Europe in 2010, being 47 of these registered in Portugal34. 
h Although lack of data prevents the last report from ESHRE to present fully precise measures of the success of treatments 
(evaluated as the proportion of clinical pregnancies and deliveries per initiated cycle), it revealed indicative data regarding 
ART success rates in Europe, in 201034: among IVF cycles, 29.2% of patients achieved a pregnancy and 22.4% delivered a 
baby; among ICSI cycles, 28.8% achieved a pregnancy with 21.1% delivering a baby; and among frozen embryo transfers, 
20.3% of patients got pregnant and 14.1% delivered a baby.  
i Usually, the diagnostic begins by a complete medical and reproductive history of the couple, namely a detailed sexual 
history3, 7. After that, the majority of the diagnostic techniques are focused on women’s bodies, involving techniques as 
laparoscopy, hysteroscopy, hysterosalpingogram, hysterosalpingography, hormonal analysis and blood testing8, while men 
typically performed a semen analysis7. 
18   |   Embryo donation for research: a patient-centred approach 
 
important element underlying patient-centred care, in the sense that it may contribute “to 
minimize the negative feelings that many patients might have, especially women, that they are to 
blame for an unsuccessful IVF treatment cycle” (6, p540). 
Embryo cryopreservation 
With the purpose of eliminating high order multiple gestations, a restrictive embryo transfer 
policy, of two embryos per cycle, is recommended77, 78, with European countries currently 
transferring 2 embryos per cycle in most treatments (56.7%)34. A single embryo transfer in selected 
groups of patients – based on woman's age, number of previous IVF/Intracytoplasmic Sperm 
Injection (ICSI) cycles and embryo quality – has been also advocated78, corresponding to 25.7% of 
all registered treatments in ESHRE’s report, in 201034. In this context, cryopreservation of better 
quality embryos is routinely available as an integral part of infertility services78j. These policies 
have contributed to an increase of cryopreserved embryos, in the cases where more embryos than 
those transferred to the uterus were generated.  
The cryopreservation technique offers patients undergoing IVF extra chances to conceive without 
the need to go through a new stimulation cycle49, 79. However, storing an increasing number of 
embryos raises concerns surrounding disputes over ownership or disposition80, 81, and poses 
problems and ethical questions to address for clinics and for patients who are requested to decide 
on the disposition of their cryopreserved embryos. While patients’ decision with regard to embryo 
disposition can involve some less problematic choices, like the transfer of cryopreserved embryos 
to the uterus in another treatment cycle, there are also controversial options, such as the physical 
destruction of embryos, the donation to another couple or donation to research. Literature has 
consistently shown that decision-making on embryo disposition is a complex and difficult 
decision-making process, being described as a source of moral and emotional distress82-85. Some 
couples report high decisional conflicts81 and some delay the decision for as long as possible82. 
Yet others report feeling pressure to make a decision86. Research also suggests that decisions on 
embryo disposition are subject to change over time80, 87, as will be further explored in this thesis. 
                                                 
j Two days after the egg retrieval, the fertilized egg has divided to become a 2- to 4-cell embryo. By the third day, a 
normally developing embryo contains approximately 6 to 10 cells and by the fifth day a fluid cavity forms in the embryo, 
and the placenta and fetal tissues begin to separate, being called a ‘blastocyst.’ Embryos are graded, and a cumulative 
embryo score is obtained according to several morphologic characteristics (number and symmetry of blastomeres, degree 
of fragmentation and presence of granulity)8. Transfer of embryos with ‘best quality’ may occur between one and six days 
after the egg retrieval8. 
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1.2 Embryo donation for research 
1.2.1 Legal and regulatory framework 
The legal and regulatory landscape on human embryo research was recently analysed by the 
European Science Foundation (ESF)88, the ESHRE89 and the International Federation of Fertility 
Societies (IFFS)90. Considering the 58 countries with coherent data on national policies or 
guidelines regarding research on human embryos in these three sources of information, more 
than one-third (n=22) bans such researchk, and 19 countries permit research only on surplus IVF 
embryos, prohibiting the creation of embryos solely for research purposesl. Six countries allow the 
creation of human embryos for research purposesm, while four permit research only on imported 
embryosn. The remaining seven countries have no legislation on human embryo researcho. 
A consensual trend in regulations, guidelines and healthcare policies of countries permitting 
research on human embryos is the need to obtain consent from the woman and the man that 
their embryos can be used in scientific studies90-92. Notwithstanding, there are differences 
between countries regarding whether the informed consent should be signed prior to the first 
treatment93, during treatment94 or after treatment is completed95. There are also differences 
regarding the maximum length for embryo storage96 (Figure 1), which may influence cross-border 
reproductive care services62, 65, 97, 98. Embryo storage limit ranges from a period of 3 years in 
Portugal, 5 years in Denmark, Egypt or Norway to 10 years in Austria, Australia or Taiwan90. It is 
possibly longer in some countries, such as the UK, where a maximum storage period of 55 years is 
provided99, and it is unlimited in Canada and Finland90. 
                                                 
k The following countries bans research on human embryos: Cameroon, Chile, China, Colombia, Croatia, Democratic 
Republic of the Congo, Dominican Republic, Ireland (Republic), Ivory Coast, Kazakhstan, Lithuania, New Zealand, Peru, 
Philippines, Senegal, Singapore, Slovakia, Taiwan, Tunisia, Uruguay, Venezuela, and Vietnam. 
l The following countries permit research only on surplus embryos: Brazil, Bulgaria, Cyprus, Czech Republic, Denmark, 
Estonia, Finland, France, Greece, Hungary, Iceland, Norway, Portugal, Slovenia, South Africa, Spain, The Netherlands, USA, 
UK. 
m Belgium, Egypt, Japan, Mexico, South Korea and Sweden allow the creation of human embryos for research purposes. 
n Austria, Germany, Italy and Switzerland permit research only on imported embryos. 
o Northern Ireland, Luxembourg, Poland, Romania, Russia, Turkey and Ukraine have no legislation on human embryo 
research. 
20   |   Embryo donation for research: a patient-centred approach 
 
 
Figure 1. Maximum length of embryo storage, by country90 
  
In Portugal, until 2006, the year in which a law regulating ART was enacted - Law No. 32 of July 26, 
2006100, there was no specific regulation on human embryo research. Since then, cryopreserved 
embryos may be used for scientific research, being prohibited their deliberate creation for 
research purposes. Experiments using these embryos must be authorized by the Conselho 
Nacional de Procriação Medicamente Assistida [National Council of Medically Assisted 
Reproduction], since they would result in present or future benefits for humanity100. Obtaining 
informed consent from the woman and the man for using their embryos in scientific studies is 
needed.  
According to the informed consent form actually in force in Portugal (see Appendix 2), couples are 
asked for giving broad consent to donate or not to donate embryos to research project and to 
other infertile couples101. Patients must write ‘Yes’ or ‘No’ in a blank square in front of the 
following statements: 1) “We consent to the use of our embryos for donation to other infertile 
couples”; 2) “We consent to the use of our embryos in scientific research projects”. This consent 
might be revoked by either member of the couple. Embryos must be kept for a maximum period 
of three years and if, within this period, the embryos are not used by the couple or have not been 
given other of the uses consented by them (donation for other couples or for research), embryos 
≤ 5 years 
Unlimited 
Until menopause 
No information 5-10 years 
(extens.) 
Legend: 
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will be thawed and eliminated. There is no national guidelines concerning the adequate moment 
for signing the informed consent. 
These principles reflect the main international trends in the legal and regulatory landscape of 
countries allowing human embryo research, particularly on the following aspects: authorization of 
research projects using only surplus embryos; requirement of evaluation of human embryo 
research projects prior to implementation by regulatory authorities and ethics committees; 
prohibition of the sale of embryos and their production solely for research; and the need to obtain 
informed consent from patients 90-92.  
There is a wide debate about the meaning of the informed consent and what is needed to 
guarantee its legitimacy and validity 102, 103, in a context where the relationship between freedom 
of action and choice, on the one hand, and influence of the medical expertise and advice, and the 
social context, on the other, emerge as an important topic of reflection. Overall, it is important 
that the consent is effectively informed (which requires an understanding of its content as well the 
comprehension of the oral and written information provided), voluntary (without any pressure or 
coercion, external or internal, concerning decision-making) and reflected (preceded by time to 
think about the decision) 91, 95, 104, 105. These elements are especially relevant when the decision 
process involves the search for consensus among partners81. However, critical approaches arising 
from social sciences and humanities discuss the conditions under which informed, voluntary and 
reflected consent is conceptualized and implemented. 
The rational-choice theory106 assumes that each individual makes their decisions in an intentional 
and objective-oriented way. Individuals hierarchically ordered their set of preferences and make 
rational calculations of costs and benefits before acting, comparing systematically all the options 
available in order to maximize utility, which is the last aim of their action. This approach is largely 
based on the postulate of autonomy, defined as the ability to act freely without constraint or 
coercion107. The individual is thus seen as an autonomous being with his or her own rights, and 
with little or no influence of social, contextual or structural factors.  
Contrasting with this perspective, social constructivist theory assumes that individuals are active 
participants in learning processes involving the social construction of knowledge which underlies 
their decisions108. Patients have access to information that is socially constructed, resulting from 
the relationships established with health professionals, being influenced by professionals’ skills to 
explain, respect and support109. Consent is regarded as a perceived and experienced process 
constructed through interactions between individuals and their social contexts, where emotions, 
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desires and feelings shape patients’ responses and decision-making. Consent is conceived as an 
ongoing process rather than as a discrete act of choice taking place in a given moment of time102, 
which calls attention for the importance of being revocable at any time.  
It has been suggested that informed consent should not be seen as the result of a purely rational 
and autonomous process of decision-making, based on a deep assessment and understanding of 
the information provided by health professionals, as it is also guided by feelings of trust in these 
professionals103. Interactions and relationships can enhance as well as restrict the autonomy to 
consent109. Thus, it is important to understand, in depth, the clinical context and the social and 
political aspects that influence the consent process102.  
In sum, the process of informed consent may constitute an opportunity for humanization, 
democratization, accountability and transparency of processes and decisions95, 110 concerned with 
ART by fostering dialogue and trust between health professionals and patients111, 112 and 
providing a space for reflecting about cryopreservation and decision-making regarding embryo 
disposition. However, it can also be reduced to a formality that may be guided by legitimate 
medical strategies to manage risks, expectations and responsibilities in the field of ART113, 114.  
In the context of clinical practices involving informed consent on embryo disposition, it is crucial 
to ground legal and regulatory frameworks on patients’ values, preferences, choices and 
expressed needs in order to lend credence and robustness to the consent that the couples give.  
This thesis will contribute to this discussion, by analysing three inter-related issues: first, the 
perceptions of couples undergoing IVF regarding the circumstances that contextualize the 
delivery and signing of the informed consent; second, patients’ opinions about the 
cryopreservation storage period offered to them; third, the existence of change in their attitudes 
over time. 
1.2.2 Expectations and controversies 
Human embryonic stem cells (hESCs) were firstly reported in November 1998, when two 
independent teams of US scientists succeeded in isolating and culturing stem cells obtained from 
human embryos and foetuses115. In 2006, researchers identified conditions that would allow some 
specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state – the 
induced pluripotent stem cells116. Since then, hundreds of stem cell lines have been derived 
worldwide using mainly remaining embryos generated after IVF treatments, and recently scientists 
in the UK have been granted permission to edit the genomes of human embryos for research117. 
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Research on human embryos, and in particular on hESCs, has engendered promising results and 
high expectations in society, but also controversial issues in ethics, practices and policies30, 88, 118. 
The development of innovative clinical solutions aiming to improve public and individual health is 
expected119, with eventual impact on the levels of satisfaction and confidence among both 
caregivers and patients120. The value of recent achievements of research on hESCs is widely 
recognized (Figure 2), in particular for neurodegenerative disorders121, transplants onto damaged 
human corneas122 or organ transplantation123.  
Despite the promising results and potential clinical applications, differences in national and 
transnational laws and policies on human embryo research have given rise to reflections 
concerning the governance of global flows of embryos, scientists and capital124-127. Critical 
approaches also focus on issues related to the management of institutional and individual 
responsibilities and the protection of human rights, namely in the following domains: status and 
protection of human embryos124, 128, 129; lack of public involvement in decision-making regarding 
funding for hESC research130 and in regulation of the information conveyed by the media in this 
process131, 132; and dissemination of unrealistic expectations concerning the results of research on 
human embryos133. In fact, contrary to what IVF patients who donate embryos for research expect, 
a recent critical review on the clinically validated stem cell-based therapies for reproductive 
diseases revealed that, to date, there are no stem cell-based therapies available to the larger 
public and outside of clinical trials directed at ameliorating or solving reproductive medicine 
issues134. 
Responsible governance on human embryo research needs to find a balance between 
expectations and controversies, empirically grounded on the assessment of the moral and ethical 
spectrum involving both scientists and stakeholders88 and the public135, in particular those people 
who must make embryo disposition decisions.  
According to the Eurobarometer survey on biotechnology carried out in February 2010136, 42% of 
the participants believe it is ethically wrong to use human embryos in medical research even if it 
might offer promising new medical treatments, while 47% disagree with such sentence and 11% 
have no opinion on this topic. Data from Portugal point to 40% of the participants considering 
human embryo research to be ethically wrong, while 42% consider that it is not ethically wrong 
and 18% do not express an opinion. Although there are differences among countries, these data 
illustrate the sensitive nature of this topic, with the public opinion being split almost evenly 
between those who agree and those who disagree that it is ethically wrong to use human 
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embryos in medical research. In this context, it is important to deepen the understanding of the 
reasons for such opinions, in particular about how the public understands science and technology.   
 
Figure 2. Examples of promising results and potential clinical applications 
of frontier research on stem cells in Europe88 
 
The science literacy model assumes that knowledge boosts public acceptance of the scientific 
worldview and that science literacy is the driving force behind public evaluations137. Contrasting 
with the idea of promoting a well-informed public opinion138, a contextualist approach to the 
public understanding of science focuses on the interactions between social context, forms of 
knowledge, the actions of “experts” and/or media use (e.g., 139-141). Literature shows that trust in 
those conducting and regulating scientific research - universities, scientists and governments - has 
been significantly associated with positive attitudes towards embryonic stem cell research142. 
Higher levels of trust are most frequently observed when research is carried out by public 
universities, which are typically perceived to serve public over and above political and business 
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interests. At the individual level, news media use and religion seemed to influence the relationship 
between the public and science and technology137. On the one hand, Christian conservatism and 
social ideology were directly associated with more negative views of embryonic stem cell research. 
On the other hand, reading about this type of research in the newspapers was associated with 
more positive views of embryonic stem cell research137. 
Beyond the public opinion, listening to the patients’ voice and assessing their real-world 
experiences is a core need for patient-centred policies on human embryo research, as they are key 
actors in this research practice112, 143, 144. A literature review on this topic will be presented in the 
next section. 
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1.2.3 Paper I. Factors associated with the donation and non-
donation of embryos for research: a systematic review 
Samorinha C, Pereira M, Machado H, Figueiredo B, Silva S 
Human Reproduction Update 2014; 20(5): 641-655 
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1.3 Patient-centred care 
1.3.1 Conceptual framework  
In 2001, the Institute of Medicine of the United States National Academies of Science established 
the patient-centred care as an indicator of high-quality healthcare that is respectful of and 
responsive to individual patient preferences, needs, and values145. Currently, patient-centred care 
has become an important global issue in health, permeating the literature and policy discourse 
internationally. The WHO´s global strategy on integrated people-centred health services for 2016-
2026 calls for a fundamental paradigm shift in the way health services are funded, managed and 
delivered146. The European Union also set out integrated, sustainable and citizen-centred care as a 
topical theme in the European Work Programme for the H2020´s Societal Challenge of Health, 
calling for action-oriented research to develop new, or improve on existing, models for health 
systems in order to make them more patient-centred147, and the International Alliance of Patients’ 
Organizations advocates and ensures its implementation worldwide148. 
The call for a patient-centred care represents a significant shift in terms of clinical practice, the 
conceptualisation of healthcare user, and the doctor-patient relationship in Western countries, 
against the predominantly paternalistic model of healthcare delivery (Figure 3). The paternalistic 
model assumes that the professional’s role is one of authority and of applying technical 
knowledge while having the obligation to keep emotional detachment from patients’ 
experiences149. Patients are regarded as helpless and passive in need of doctors’ expert 
knowledge, who are in total control of the situation and have to make the decisions for the 
patient150. According to this approach, which is still in force nowadays151, 152, the “sick person” (the 
patient) is expected to assume his/her condition of disabled, which releases him/her from fulfilling 
normal social obligations, and to cooperate fully with the doctor, while doctors are expected to 
apply their specialist knowledge and skills for the benefit of the patient149. Parsons, following 
structural-functionalist principles, viewed health as a functional prerequisite of society and illness 
as a form of social deviance, where doctor and patient assumed complementary roles149. In this 
way, the “sick role” is acknowledged by Parsons also as a social role and not only as a "condition", 
in the sense that both roles fit into the general equilibrium of the social system.  
The paternalistic model is underpinned by a biomedical conception of illness153, in which patients 
are approached as physical beings whose signs and symptoms indicate the presence or absence 
of illness after being evaluated and diagnosed by the medical doctor154. According to this 
perspective, disease exists as a distinct entity and the individual patient is a passive site of disease 
manifestation154.  
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Figure 3. A timeline indicating the evolution of the doctor-patient relationship since 1800s155 
The assumptions of the paternalistic model were initially challenged by the emergence of 
psychology, in particular the psychoanalytical and psychosocial theories of Breuer and Freud156, as 
well as Carl Rogers’ distinctive approach to understand personality and human relationships157 - 
the person-centred therapy, which highlighted the importance of listening to the patient as a 
subject, developing a genuine communicative relationship and viewing the patient as an active 
agent. Moreover, the importance of analysing the patient’s unique psychological and social 
context and developing an emotional relationship to create good therapeutic and diagnostic 
processes was also argued by Balint158. 
This move towards a biopsychosocial understanding of disease broadened the biomedical 
explanatory perspective on illness to include social and psychological factors and mutual 
participation of doctor and patient in the caring relationship153. The figure of “doctor-as-a-
person”, rather than simply a total expert, emerged in this context, henceforth viewed as someone 
who shared power and responsibility with the patient159. At the same time, a renewed focus on 
understanding patients’ experiences was observed160, along with changes in the way the patient is 
conceptualised, with his/her role moving from one of passive recipient of care to one of “co-
producer of health” (162, p8), an active subject in self-care management, and also in the 
governance and improvement of services159, 161, 162. Being  seen as a social, emotional and physical 
being, the “patient-as-a-person” makes interpretations of treatment and attributes meanings to 
illness according to his/her individual experience159, which is fundamental to evaluate the quality 
of healthcare and to understand how health systems can better respond to the needs of all 
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healthcare stakeholders and constituencies in a holistic manner112. The assessment of the quality 
of healthcare system then began to include the patients’ right to be fully informed, to be treated 
with respect and to be actively involved in the decision-making processes about treatment. 
Shifts in care paradigms occur in parallel with wider social, policy and healthcare system changes. 
Reconfigurations in public expectations about healthcare delivery were observed112, 161 due to 
higher levels of education, increased availability of information (namely through internet), a move 
towards market models of care, growing consumerism and larger access to goods and services, 
and an increasing emphasis on democratic values (e.g., citizens as with the right to claim quality 
healthcare). A discourse based on the idea of greater humanization of services coexists with an 
increasing emphasis on patients’ responsibilities and the individualisation of health, which have 
given rise to a redefinition of patients as consumers in scenarios circumscribed by neoliberalism 
and market-orientated models of care and 163. The concept of healthcare users as consumers 
inspired several policy documents in countries such as the United Kingdom, the United States and 
Australia161, 164, 165, being translated in an appeal to the health authorities to make services which 
are more responsive to patients through consultation processes.  
The rhetoric underlying these proposals suggests the possibility of achieving “a higher level of 
performance and adopt a more humanistic and holistic approach to healthcare, where the 
individual who needs care is viewed and respected as a whole person with multidimensional 
needs” (137, p4). However, it might form a moral landscape that points to the duty of all citizens 
to exercise an "active citizenship", masking class and gender differences or socioeconomic 
inequalities that may limit or even prevent their effective exercise166. It is also claimed that the 
emphasis on patient choice, individual responsibility and agency with respect to personal health 
and wellbeing asks patients to use their own resources (e.g., time and knowledge) to self-regulate 
and to ensure they remain healthy163, 167, in line with the idea of an “expert patient”, i.e., patient as 
an expert of his own health condition, as an ‘engaged’, ‘empowered’ or ‘activated patient’. This 
idea has been promoted, to a large extent, by the underlining connection made between ‘self-care 
management’, better health outcomes and cost effectiveness of interventions168, 169, which 
mobilization is often triggered in contexts where the scarcity of resources supports constraints in 
healthcare provision170. 
Patient-centredness was firstly advocated in 1976 by Byrne and Long171. Their work started with 
the assessment of doctor's verbal behaviour in the consultation, in order to summarize the 
doctor's interview style. From the analysis of about 2000 audiotaped consultations, carried out 
over three years and a half, these authors found a continuum of general practitioner consulting 
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styles ranging from “doctor-centred” to “patient-centred”171. The “doctor-centred” consultations 
were characterized by a predominance of doctor’s medical knowledge, who gave direction to 
patients. On the opposite side, “patient-centred consultations” recognized patient’s needs and 
preferences; doctors listened and encouraged patients to express their needs. In this perspective, 
patient-centredness was firstly defined as a style of doctor-patient interaction in which the main 
elements to take into account were how medical power was shared between doctors and patients 
and how patients were involved in consultations. Later, Mead and Bower159 referred to these 
interactions, characterised by the power and responsibility exchange between doctor and patient, 
as “therapeutic alliance” in which the patient involvement  in treatment decisions became 
possible.  
The patient-centred care was included as a Medical Subject Heading (MeSH) in 1995 and has been 
conceptualized through the following core dimensions145, 159, 172, 173: 
 Respect for patients’ values, preferences, choices, and expressed needs (where attention is 
required to aspects such as quality of life, involvement in decision-making, dignity, needs and 
autonomy). The health system should be designed to meet the most common types of needs, 
but should also have the capability to respond to individual patient choices and preferences. 
Also, it should be able to accommodate differences in patient preferences and encourage 
shared decision-making. 
 Patient involvement in health policy. Patients and patients’ organizations have a valuable role 
to play in healthcare policy-making through meaningful and supported engagement in all 
levels and at all points of decision-making to ensure that they are designed with the patient at 
the centre. 
 Coordination and integration of care (importance of assuring that accurate and timely 
information reaches those who need it at the appropriate time).  
 Information, communication, and education (trustworthy and accurate information that is 
attentive, responsive, and tailored to an individual’s needs). Patients should have access to 
their own medical information and to clinical knowledge; and clinicians and patients should 
communicate effectively and share information. Patients should also receive care based on the 
best available scientific knowledge and it should not vary from clinician to clinician or from 
place to place. 
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 Physical comfort (timely, tailored, and expert management of symptoms of pain, shortness of 
breath, or some other discomfort).  
 Emotional support – intended as relieving fear and anxiety (taking into account all the 
distressing symptoms and the significant emotional and spiritual dimensions of the individual. 
Attention is required on the impact of the illness on self and family; and over the financial 
impact of the illness). The health system should anticipate patient needs, rather than simply 
react to events. 
 Involvement of family and friends (accommodation of family and friends, involving family in 
decision-making, supporting the family as caregiver, recognising the needs and contributions 
of the family). This should include information describing the system’s performance on safety, 
evidence-based practice, and patient satisfaction.  
The implementation and evaluation of these dimensions of patient-centred care are complex and 
context-dependent, they are neither consensual nor are necessarily translated in the improvement 
of health care174-176. On the one side, the evaluation of patient-centred care has been defined and 
implemented by the healthcare services themselves, which may hamper the search for a grounded 
understanding about how people experience health, illness, treatment and the delivery of care160. 
Therefore, the inclusion of patients’ voices in guidelines and quality standard development 
processes176, 177 is essential to promote service responsiveness, particularly when neoliberal 
rationalities underlying policy and services can prevent patients from seeing themselves as 
subjects of rights, including the right to quality care167. 
On the other side, the implementation of patient-centred care requires individual, organizational 
and political changes in order to promote adjustments in the established social and professional 
roles, in attitudes and in the knowledge which traditionally sustains the interactions and decisions 
in the healthcare system178, 179. The different healthcare professional groups, as well as patients, 
need to incorporate the principles and goals of patient-centredness as pillars of their existing 
professional and social identities174. This requires changes in the power and knowledge hierarchies 
underlying doctor-patient relationship176, which are able to support the development of 
collaborative relationships180. However, the engagement of healthcare professionals might be 
undermined by the new public management principles, which  are intended to meet increasing 
needs and demands of patients, while simultaneously achieving the most rational and efficient 
performance at the lowest cost181, 182 by directing professionals for productivity aims183 rather than 
encourage them to listen to the views and perspectives of patients. In this sense, while patient-
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centred care may liberate the medical encounter from paternalistic power, at the same time it 
introduces a new complex of power relations between doctors and patients103. 
1.3.2 Patient-centredness in infertility and ART 
It is now widely recognized that high quality infertility care comprises more than just the 
effectiveness of care146, 184 and should be patient-centred36, 42, 185. However, its implementation is 
faces particular challenges. For example, the fact that the subject of treatment is most often a 
couple involves reconfigurations on the medical procedures, on the type of information that 
should be provided and on the type of interactions upheld, creating a different sort of doctor-
patient relationship, which moves from a dyad to a triad186. Also the search for cross-border care 
in reproductive medicine, particularly in Europe59, 187, adds additional concerns regarding the 
development and implementation of policies and guidelines to guarantee the delivery of optimal 
care and patient-centred treatments among the different local, cultural, socioeconomic and 
political contexts regulating ART143.  
Studies on patient-centredness in infertility and ART have mainly focused on the following topics: 
i) evaluation of patients’ experiences with infertility care188-191, with an emphasis on gender 
differences192-194, and respective comparison with health professionals’ perceptions of patients’ 
experiences195-197; ii) association between patient-centred care and health outcomes, in particular 
patients’ quality of life and feelings of distress39, 42; iii) development of guidelines for the 
implementation of patient-centred care198; iv) evaluation of the effect of physician training in 
empathic skills199, as well as giving feedback to health professionals about patients’ experiences 
on patient satisfaction and healthcare quality improvement195, 200.  
Most of these studies were conducted in European countries and the great majority was carried 
out in the Netherlands and Belgium. The assessment of the concept has relied on quantitative 
instruments39, 42, 188, 189, 193-197, 199-207 , on the qualitative analysis of patients’ experiences and 
narratives191, 198, 208-215 and on mixed-methods studies190, 200. Quantitative assessment has been 
based on self-report instruments. The most used valid and reliable instrument is the “Patient 
Centredness Questionnaire – Infertility (PCQ-Infertility)”188 (see also e.g., 39, 42, 193, 195, 200, 204). PCQ-
Infertility consists of a 46-items questionnaire, divided in an overall score of patient-centredness 
and seven subscales: accessibility, information, communication, patient involvement, respect for 
patients’ values, continuity and transition, and competence. Another questionnaire is the “Quality 
from the Patient’s Perspective of In Vitro Fertilization” (QPP-IVF)192. It is divided into 10 subscales: 
pain relief and physical care, waiting time, care room characteristics, information during treatment, 
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information after treatment, participation, responsibility/continuity, the staff’s 
respect/commitment/empathy, atmosphere and environment and availability. The measurements 
consisted of two kinds of evaluations: the rating of the importance of various aspects of treatment 
(subjective importance) and the rating of perceived quality of care (perceived reality). Other 
authors used questionnaires designed for their studies194, 196, 197, 199 or specific to conditions, such 
as endometriosis201, 202. Qualitative studies relied on the use of interviews211, 213-215, focus groups190, 
198, 208, 209, the Delphi technique191 and ethnographic observation103. 
The few studies examining IVF patients’ perspectives on care as their primary aim concluded that 
patients expressed the need for medical skills but also for respect, coordination, accessibility, 
information, comfort, support, partner involvement and a good attitude of and relationship with 
fertility clinic staff (Figure 4)143. 
 
PATIENT-CENTRED INFERTILITY CARE 
SYSTEM FACTORS         HUMAN FACTORS 
Information  
Competence of clinic and staff 
 Attitude of and relationship  
with Staff 
Coordination and Integration  Communication 
Accessibility INTERACTION Patient Involvement and Privacy 
Continuity and Transition  Emotional Support 
Physical Comfort   
   
Figure 4. The interaction model of patient-centred infertility care208 
 
Some studies showed that patients considered that respect, autonomy and partner involvement 
were strengths in their fertility centre190 while waiting times, information provision, emotional 
support188 and doctors’ continuity during the treatment188, 190 were valuable dimensions that 
needed improvement in order to attain a higher level of patient-centredness189, 190. Provision of 
information and accessibility were ranked as top priorities for IVF patients209. They also presented 
a desire to have free access to their own medical record188; the need to have a report on 
treatment outcomes and complications, and on the results of semen analyses in a standardized 
way; to be provided with information on the negative consequences for achieving a pregnancy in 
case of a high BMI; and to have counselling about the positive effects of the elimination of a 
‘harmful lifestyle’ on their chance of getting pregnant191. Importance of medical care and 
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‘information after treatment’ were emphasized by both partners in a study from Holter et al.192. 
Patients appreciated the opportunity to question and clarify doubts with the health professionals, 
as well as the time they dedicate to communicate in a reliable and comprehensive way, stressing 
the importance of the communication skills (e.g., do not induce fear, introduce themselves at the 
beginning of treatment or provide information on what is expected to happen during 
treatment)208. 
Patients and health professionals tended to agree on the perception of the overall level of 
patient-centredness in infertility care195, with both groups attributing the highest value to 
indicators of information and communication198. Notwithstanding, differences in the perspectives 
of doctors and patients on the specific valued dimensions of patient-centredness of a fertility 
centre were registered191, 195, 196. While patients emphasized accessibility of care, professionals 
emphasized coordination and integration as important quality measures for patient-centredness 
in infertility care191. Also, patients valued the physicians’ attitude as the highest priority relative to 
other attributes, but physicians underestimated the importance of their own attitude and 
overvalued treatment effectiveness196, 197.  
Moreover, significant gender differences were found within heterosexual couples in the evaluation 
of the most important dimensions of patient-centredness: women rated all the aspects of care 
during IVF as more important than their partners, except ‘responsibility/continuity’192. Other study 
found that although no differences were observed in the PCQ-Infertility total score between 
women and their partners, men scored higher on the subscales ‘respect for patients values’ and 
‘staff’s competence’193. The narratives of women undergoing treatment also revealed the 
importance attached to relational dimensions, highlighting the need for social support as an 
integral part of strategies to deal positively with the difficulties along the process211. Regarding 
the association between level of patient-centredness and patient outcomes, patient-centred care 
was associated with wellbeing during treatment103, 191. Higher levels of patient-centredness in 
infertility care seemed to be associated with better quality of life and lower levels of anxiety and 
depression among women undergoing infertility treatment42. Information provision and continuity 
of care were indirectly associated with better individual wellbeing39, 103, 191, 204, 207, the first via lower 
treatment concerns and the second via higher treatment tolerability39. Positive experiences 
regarding information received, respect from staff about values and preferences, continuity in 
treatment and competence of staff were also directly associated with higher compliance 
intentions204. Competence, accessibility, continuity and communication were indirectly associated 
with better relational wellbeing via higher treatment tolerability39, as well as with higher levels of 
trust in health professional103. Moreover, the level of patient-centred care significantly influenced 
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patients’ choice of a fertility clinic200, with the lack of patient-centredness emerging as the most 
cited non-medical reason for changing fertility clinics197.  
However, Gerrits103 also explored the “unintended effects” from patient-centredness. While 
patient-centred practices are reported to facilitate informed decision-making and to provide 
emotional support for couples, they may also have unintended disciplining and normalizing 
effects. This can happen, for example, when the intention to provide the patients with the ability 
to cope with all the adverse outcomes of treatment contributes, paradoxically, to "normalize" the 
burden of treatment, which is one of the undesirable effects of the implementation of patient-
centred care103.  
Training empathic physicians’ skills seemed to have resulted in higher patient satisfaction levels 
on the perceived information quality, communication skills and time dedicated at first 
consultation for infertility treatment199. Besides that, Aarts and colleagues195 pointed as a possible 
tool to start improvement of patient-centredness and quality of care to provide detailed feedback 
of patients’ opinions to health professionals. However, a recent study showed that merely 
providing auditing and feedback to professionals in infertility care about their performance on 
patient-centeredness may not be sufficient to increase the level of this important dimension of 
quality of care193 as well as to increase the fit between the care provided at different points in 
treatment and patients’ needs39. 
In sum, assessing the level of patient-centredness is essential for clinics to have detailed insight 
into their performance in the perspective of patients. That will allow them to tailor quality 
improvement and benchmarking188. Beyond individual clinicians, it is also fundamental to provide 
actionable feedback to stakeholders in health systems and public health practitioners about what 
needs to be changed to achieve patient-centred care185. This includes the discussion of broader 
political changes needed to empower people to manage their own health, such as the social 
determinants of health175.  
Although methods for determining the level of patient-centredness of care are proposed to rely 
on assessing patients’ specific experiences with care delivery, rather than on surveys measuring 
global satisfaction190, 195, and most research evidence sustains the development of a relational 
ethics in the clinical practice, existing studies using a patient-centred approach do not explore the 
specific process of decision-making on embryo disposition, namely embryo donation for research. 
Taking into account the centrality of adequate and timely information, communication and patient 
                                                                                                                                                                   Introduction   |   53 
   
involvement to promote patient-centredness, the informed consent is a fundamental tool and 
process on embryo disposition, which study has been scarce in this context.  
Knowledge on patient’s perspectives and experiences with regard to embryo donation for 
research is essential for the conceptualization of patient-centred policies and for ethics in clinical 
practice at the following levels: to analyse openness and information about research with human 
embryos; to sustain stakeholders’ decisions regarding the suitability of research projects using 
cryopreserved embryos; and to disseminate ethically robust evidence to inform policies and 
guidelines on embryo cryopreservation and embryo disposition, namely concerning the informed 
consent design and its implementation. Thus, a renewed debate that includes the views of 
patients about the legal and regulatory contexts that frame the clinical practice is needed. This 
thesis’ results intend to contribute to answer to this challenge by analysing embryo donation for 
research, based on a patient-centred care approach. 
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56   |   Embryo donation for research: a patient-centred approach 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                   Objectives   |   57 
   
Research on human embryos, and particularly on hESCs, has engendered promising results and 
high expectations in society regarding the improvement of public and individual health, but also 
controversial issues in ethics, practices and policies30, 88, 118. Reflections concerning the responsible 
governance of human embryo research sustain the relevance of listening to the patients’ voice 
and assessing their experiences as a core need for patient-centred care and policies on human 
embryo research, as they are key actors in this research practice112, 143, 144.  
In fact, most couples enrolled in ART treatments need to make decisions regarding embryo 
disposition216-218, as they are usually asked to sign a consent form concerning embryo donation 
for research. The consent should be informed (which requires an understanding of its content as 
well the comprehension of the oral and written information provided additionally), voluntary 
(without any pressure or coercion, external or internal, concerning decision-making) and reflected 
(preceded by time to think)91, 95, 104, 105.  
Beyond implementation of evidenced-based practices in the field of informed consent on embryo 
disposition, it is crucial to ground legal and regulatory frameworks on patients’ values, 
preferences, choices, and expressed needs in order to lend credence and robustness to the 
consent that the couples give. However, existing studies using a patient-centred approach do not 
explore the specific process of decision-making on embryo disposition, namely embryo donation 
for research, and there is no available evidence on this topic to ensure feasibility to guideline 
development36.  
Thus, knowledge on patients’ experiences and perspectives about the healthcare and regulatory 
system, and on the human factors involved in the decision-making process regarding embryo 
donation for research, is needed to improve patient-centredness in the field of ART. This thesis 
will focus on the following three main levels underlying decision-making on embryo disposition 
that cross the boundaries between evidenced-based practices for clinical purposes and evidence 
regarding political, legal and regulatory contexts: the sociodemographic, reproductive and 
psychosocial characteristics and reasons associated with willingness to donate embryos for 
research; the perceptions about storage limits for embryos; the circumstances under which the 
informed consent should be delivered, explained and signed. 
Results relating to the influence of sociodemographic characteristics and reproductive and 
gynaecological history on the decisions of IVF patients regarding embryo donation for research 
are mostly inconclusive. Moreover, some psychosocial factors generally associated with patients’ 
experiences of IVF treatments, in particular those related to couples’ relationship, the meanings of 
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parenthood and social support, as well as personal well-being and psychopathological symptoms, 
are absent from most of the studies219. Obtaining knowledge on these factors is a core need to 
identify the determinants of the decision and to better understand how partner dynamics and 
gender differences affect couples’ decision, providing valuable insights into psychosocial care in 
ART. It also contributes to analyse openness and expectations about research with human 
embryos, and to sustain stakeholders’ decisions regarding the suitability of research projects using 
cryopreserved embryos in accordance with patients’ expectations. 
Beyond data provided by the cross-sectional studies, those with a longitudinal design call 
attention to the fact that decision-making on embryo disposition is subject to change over time. 
From the few existing longitudinal studies about the factors associated with patients’ willingness 
to donate embryos for research none focused on the influence of psychosocial, demographic and 
reproductive characteristics. At the same time, patients’ needs for information and support are 
likely to vary across treatment stages36. In this context, the timing set to obtain consent, as well as 
the embryo storage time limits, constitute two key regulatory issues which are likely to influence 
the type of decisions made regarding embryo donation for research. Currently, there is no 
consensual evidence on whether the informed consent should be signed prior to the first 
treatment93, during treatment94 or after treatment is completed95, and the establishment of 
current storage limit for embryos has been based more on social and political criteria, with no 
scientific evidence underlying the implemented storage periods96, 220-223. Thus, obtaining 
knowledge on how patients’ attitudes about embryo disposition evolve over time, as well as on 
patients’ opinions about the storage limit for embryos, is needed to guide patient-centredness in 
infertility and ART. This data can be useful in developing knowledge and patient-centred 
information concerning storage periods and the reasons for limitations, in a context in which 
patients’ views are taken into consideration across legal and political boundaries. Such knowledge 
may also help in enacting guidelines to regulate applications to define embryo storage, as well as 
to set the timing for obtaining informed consent.   
Overall, the literature on patients’ perspectives on embryo donation for research has neglected 
the analysis of the conditions in which the informed consent is implemented. The process of 
informed consent may constitute an opportunity for humanization, democratization, 
accountability and transparency of processes and decisions95, 110, concerned with ART by fostering 
dialogue and trust between health professionals and patients111, 112 and providing a space for 
reflecting about cryopreservation and decision-making regarding embryo disposition. However, it 
can also be reduced to a formality that may be guided by medical strategies to manage risks, 
expectations and responsibilities in the field of ART113, 114. Given the inconsistency in the guidelines 
                                                                                                                                   Objectives   |   59 
   
for clinical practices regarding informed consent, a central tool in decision-making process, 
knowledge on the perceptions of IVF couples regarding the factors that contextualize informed 
consent on embryo disposition, in particular the circumstances under which it should be delivered, 
explained and signed, are essential to guide patient-centredness in infertility and ART. 
This thesis aims to produce evidence to sustain the development of patient-centredness regarding 
embryo donation for research, by the accomplishment of the following specific objectives: 
1) To assess the psychosocial, demographic and reproductive factors and socioethical reasons 
associated with willingness to donate embryos for research among couples undergoing IVF. 
2) To analyse IVF couple’s willingness to donate cryopreserved embryos for research over time, 
taking into account the influence of psychosocial, demographic and reproductive factors. 
3) To assess IVF patients’ opinions about the storage limit for embryos and to explore their 
perceptions of the criteria underlying the establishment of the storage period offered to them.  
4) To analyse the perceptions of IVF couples regarding the factors that contextualize informed 
consent regarding embryo cryopreservation. 
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3.1 Study design 
This work is based on an observational and longitudinal mixed-methods study. This design 
involves collecting quantitative and qualitative data, alternating between sides over time224. The 
methodological strategy relied on three evaluation moments: (1) quantitative questionnaire with 
couples in IVF/ICSI treatments, over 12 consecutive months (baseline); (2) semi-structured 
interviews to a subsample of couples, conducted 3 months after baseline; (3) quantitative 
questionnaires 12 months after baseline (Figure 5). 
 
 
Figure 5. Study design 
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3.2 Participants and data collection 
3.2.1 Questionnaires at baseline 
Between the 17th of August 2011 and the 16th of August 2012, all patients undergoing IVF or 
Intracytoplasmic Sperm Injection (ICSI) in one reproductive medicine centre in Porto, Portugal, 
were consecutively and systematically invited to participate in the study on the day biological 
samples were collected to diagnose pregnancy, using the Human Chorionic Gonadotropin test – 
βhCG (N=329 tests), about 15 days after embryo transfer, being interviewed while awaiting for the 
results (Figure 6). In this centre, couples with cryopreserved embryos had signed the informed 
consent about embryo disposition after embryo transfer. This fertility centre is located in a public 
University Hospital that performs IVF/ICSI homologous cycles and does not conduct research 
projects using human embryos.  
The research protocol was designed to recruit heterosexual couples because, in Portugal, IVF users 
must be heterosexual and married (or be in a stable relationship for at least 2 years)225. The choice 
of the day of the diagnosis of pregnancy was based on the fact that this procedure may require 
the presence of the couple, after a physically and emotionally challenging treatment226, 227.  
 
 
 
Patients were first approached by nurses and given a study information sheet (see Appendix 1). 
This sheet had several sections, namely: 1) explanation on the purposes and design of the study; 
2) potential risks and benefits of participating, issues of privacy and confidentiality, including 
Figure 6. Moment of administration of questionnaires at baseline 
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duration of the questionnaire (30 minutes on average); and 3) information about patients’ right to 
refuse to participate in the study or to withdraw consent to participate at any time without reprisal 
or any influence in their treatment. Patients read the information sheet and one member of the 
research team then invited the potential participants to participate in the study, responding to all 
of their questions. Patients who decided to participate in the study were accompanied to a private 
room in the reproductive centre, where they read and signed the informed consent, and the data 
gathering started afterwards.  
Of the 329 eligible patients, 226 visited the hospital with a partner and 103 women went to the 
hospital alone. Of the 226 couples invited, 221 agreed to participate in the study and among 
women alone, 92 participated, with participation rates of 97.8% and 89.3%, respectively (Figure 7). 
The global participation rate was 95.1%. 
 
Figure 7. Flowchart for sample recruitment 
 
The characteristics of the participants, stratified by gender, are presented in Table 1. Regarding 
couples’ characteristics (n=221 couples), most of them were in a relationship for more than 5 
years (73.7%) and had a household income higher than 1500€/month (58.1%). Most couples had 
never been pregnant (67.0%), had a duration of infertility superior to 3 years and had performed 
at least one previous cycle (56.1%). Regarding the causes for using ART, 27.6% had a female 
cause, 32.1% had a male cause and 40.3% had a mixed (female and male) or unexplained cause. 
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Table 1. Demographic, reproductive and psychosocial characteristics of the participants, 
stratified by gender 
 
 
Two trained female interviewers conducted face-to-face interviews with the couples, using 
structured questionnaires. The outcome - willingness to donate embryos for research - was 
assessed by the question: “[When you are no longer using your embryos for your own treatment] 
Did you consent/ Would you consent the use of your embryos in scientific research projects?” and 
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was categorized as “yes” or “no” to donation. The agreement between the couple to donate/not 
to donate embryos for research was also assessed. Data was also collected on: demographic 
characteristics (age, education level, country of origin, religion, household monthly income, 
subjective social class and length of relationship) and reproductive history (parental status, 
duration of infertility, number of previous cycles and causes of infertility) and the importance 
attributed to embryo research. Religious belief was categorized as a yes/no response to being 
Catholic, given the high prevalence of Catholic religion in Portugal228. Religious practice was 
assessed through the frequency of participation in religious services. Answers were categorized as 
“at least once a month” (including the options “many times a week”, “once a week”, “two or three 
times a month” and “at least once a month”) or “less than once a month” (including the options 
“many times a year”, “once a year”, “less than once a year” and “never”). The importance attributed 
to human embryo research was measured through the answer to the following question: “How 
important is research with human embryos for you?”. The original scale had the following 
categories: “Very important”, “Important”, “A little important” and “Not important”. Given the fact 
that all participants answered “Very important” or “Important”, the variable was dichotomized into 
“Very important” and “Important”.  
The two main individual reasons underlying their willingness to donate embryos for research were 
assessed through one open-ended question, which was included to collect more detailed and 
complete responses and to develop appropriate response categories229: “In your opinion, what are 
the main reasons to donate/not to donate embryos for research?”. 
Data on anxiety (state and trait), depression, partner relationship and perceived social support 
were collected through self-administered questionnaires that were completed individually and 
consisted of scales validated in Portuguese samples. The State-Trait Anxiety Inventory (STAI)230 is 
composed of two scales of twenty items each, Trait (a permanent condition of anxiety) and State 
(anxiety in a specific situation), on a 4-point Likert scale (scale range: 20 to 80). Lower values 
indicate lower anxiety symptoms. The Portuguese STAI231 has shown good internal consistency 
(α= 0.93 for the State Scale and α= 0.89 for the Trait Scale). 
The Edinburgh Postnatal Depression Scale (EPDS)232 consists of 10 items on a 4-point Likert scale 
(scale range: 0 to 30). Lower values indicate fewer depressive symptoms. It is reliable for the 
evaluation of depression not only in the postnatal period but also in the prenatal period233, and 
addresses symptoms of depression within the previous 7 days. The Portuguese EPDS presented 
good internal consistency (α= 0.85).  
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The Relationship Questionnaire (RQ)234 is comprised of 12 items on a 4-point Likert scale. The 
questionnaire was designed to assess two independent dimensions of the partner relationship: 1) 
the positive relationship subscale, which includes a sense of support and care, as well as affection, 
closeness and joint interests and activities, and 2) the negative relationship subscale, which 
includes anxiety, irritability and criticism. Higher scores, in the positive relationship subscale, mean 
that positive relationship dimensions are more present (range: 8-32), while higher scores, in the 
negative relationship subscale, mean that negative relationship dimensions are more present 
(range: 4-16). The questionnaire presented a good internal consistency (α= 0.79 for the total scale, 
α= 0.90 for the positive sub-scale and α= 0.72 for the negative sub-scale) and test–retest 
reliability (r= 50.74 for the total scale). 
The Multidimensional Scale of Perceived Social Support235 measures the perceived social support 
received from a significant other, family and friends, through 12 items on a 7-point Likert scale 
(total scale range: 12-84). Each subscale has four items (range: 4-28). Higher values indicate the 
perception of a better social support. 
3.2.2 Questionnaires at 12 months 
Approximately 12 months after completing the quantitative questionnaire applied at baseline, at 
the period starting one year after patients undergo their last treatment cycle, i.e. in ESHRE’s “after 
treatment” stage36, all the participants who previously agreed to be invited to participate in this 
phase of the study were contacted by telephone or email (according to their preference). Those 
who agreed to be included in the 12-months after evaluation were sent the questionnaire, as well 
as the informed consent form, by mail. This questionnaire included the same question regarding 
the willingness to donate embryos for research, questions about reproductive and obstetric data 
of the last year and the same self-administered scales for collecting data on anxiety (state and 
trait), depression, social support and partner relationship. Prepaid return envelopes were sent 
together. A total of 221 participants (114 women and 107 men) returned the questionnaires 
(participation rate=41.4%), in a total of 104 couples. 
Longitudinal analysis was only performed with the couples who participated both at baseline and 
12 months later, in a total of 82 couples (164 patients). Comparing participants who participated 
in the evaluation 12 months later with those who did not participate, the non-participants 
presented higher scores in the negative dimensions of the partner relationship than participants 
(respectively, Md [P25-P75]= 9.00 [8.00-10.00] vs 8.00 [7.00-10.00], p = 0.023). Besides that, no 
significant differences were found regarding psychosocial and reproductive characteristics and the 
willingness to donate embryos for research between these groups (Table 2). 
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Table 2. Comparison between the demographic, reproductive and psychosocial characteristics 
of the participants and the non-participants in couple, at time 2. 
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3.2.3 Semi-structured interviews 
Approximately three months after completing the questionnaire, at baseline, a sub-sample of the 
participants who agreed to participate in a qualitative interview were contacted by telephone or 
email, according to their preference, to confirm their availability to collaborate in the study. 
Between February and November 2012, 56 couples were consecutively invited to participate in the 
interview, and 34 accepted. Of the 22 couples who refused to be interviewed, more than half (n = 
13) did not show the reasons for such refusal, 4 alleged lack of availability, 3 mentioned emotional 
obstacles, one couple invoked illness of one of the partners and another couple reported being 
separated. 
Participants were purposively sampled to include pregnant and non-pregnant women, and 
couples who donated and who did not donate embryos for research. In addition, a heterogeneity 
sampling was used for maximum variation of views and experiences, until thematic saturation was 
reached. Therefore, recruitment continued until no new themes emerged from the interview 
data236. The characteristics of the interviewees are summarized in Table 3. 
Semi-structured interviews took place between March and December 2012, and all were 
conducted by the same female interviewer. These occurred at the university department 
responsible for the study (n=16), couples’ home (n=17) and at workplace (n=1). Interview duration 
ranged from 62 to 111 minutes, with an average of 81 minutes. All were taped, transcribed 
verbatim and accuracy has been checked. 
The interview guide covered the following issues: meanings of parenthood; views, values, and 
knowledge actualised to understand the status of embryos; expectations, uncertainties, and 
responsibilities associated to the embryos cryopreservation; awareness of the processes of 
evaluation and classification of the embryos’ quality and viability; how IVF couples made their 
decisions about donating embryos and their views of the consent process; and their 
understandings and knowledge of embryo research. 
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Table 3. Characteristics of the interviewed couples 
Interview* 
Age Education level (years) Embryo donation 
for research 
Pregnancy 
Women Men Women Men 
E1 28 27 >12 ≤12 Yes Yes 
E2 36 28 >12 >12 Yes Yes 
E3 34 40 >12 ≤12 Yes Yes 
E4 37 41 >12 >12 Yes No 
E5 38 36 >12 >12 Yes No 
E6 35 43 >12 >12 No No 
E7 35 38 >12 >12 Yes Yes 
E8 33 33 12 ≤12 Yes Yes 
E9 38 39 >12 ≤12 Yes No 
E10 25 30 >12 >12 Yes No 
E11 26 29 ≤12 ≤12 Yes No 
E12 37 35 ≤12 ≤12 No No 
E13 31 36 >12 ≤12 Yes Yes 
E14 27 34 ≤12      ≤12        Yes No 
E15 40 37 ≤12 ≤12 Yes No 
E16 34 36 >12 >12 Yes No 
E17 36 36 >12 >12 Yes No 
E18 33 32 ≤12 ≤12 Yes Yes 
E19 38 35 >12 >12 No No 
E20 39 42 >12 >12 Yes Yes 
E21 38 38 >12 >12 Yes No 
E22 30 40 >12 >12 Yes Yes 
E23 37 40 ≤12 ≤12 No Yes 
E24 38 35 ≤12 ≤12 No Yes 
E25 26 33 ≤12 ≤12 Yes No 
E26 34 33 >12 >12 No Yes 
E27 37 41 >12 >12 No No 
E28 38 34 ≤12 ≤12 No Yes 
E29 33 33 >12 >12 Yes Yes 
E30 35 46 ≤12 ≤12 Yes Yes 
E31 39 39 ≤12 >12 No Yes 
E32 34 35 >12 >12 Yes No 
E33 36 38 >12 >12 Yes No 
E34 32 34 >12 >12 Yes No 
*Participants are described in the table following the order of interview; the alphanumeric code assigned to each couple 
corresponds to the number of interview order. 
 
 
3.3 Data analysis 
Quantitative data 
Statistical analyses were performed using the IBM Statistical Package for the Social Sciences 
(SPSS) Statistics for Windows (versions 20.0 and 21.0), Armonk, NY, USA, Stata V.11.0 (College 
Station, Texas, USA, 2009) and the R Software (2013). Data was described as counts and 
proportions for categorical variables, mean and standard deviation for normally distributed 
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continuous variables, and median and interquartile range for non-normally distributed continuous 
variables. The prevalence of the outcomes was presented with 95% Confidence Interval (95% CI).  
According to the specific objectives of each paper, different analytic approaches were considered. 
Chi-square test or Fisher’s exact test were used to assess the independent associations between 
the categorical variables (demographic and reproductive characteristics) and the outcome. For 
continuous variables (STAI, EPDS, RQ and social support), mean or median differences were 
compared by the Independent Samples t-test or the Mann-Whitney test, according to data 
distribution. For these variables, the scores for each individual were calculated using its arithmetic 
mean for each scale.  
The associations between explanatory variables and the outcomes were estimated by crude and 
adjusted odds ratios (OR) and the corresponding 95% CI using using binary logistic regression or 
multivariate logistic regression models, adjusting for possible confounders in each study.  
Moreover, generalized Estimation Equation models with exchangeable correlation structure were 
performed. Relative Risks (RR) and the corresponding 95% confidence intervals (95% CI) were 
estimated by a log link function with a Poisson distribution.  
Qualitative data 
Semi-structured interviews were analysed using NVivo10 (QSR International, USA, 2013). Protocols 
for content analysis were selected according to the objectives of each study. Stemler’s protocol237 
was useful when we intended to categorise data and determine the frequencies of categories. It 
differs from more ‘qualitative’ methods in that it requires categorization to be sufficiently precise 
to allow multiple coders to achieve the same results, relying on the systematic application of rules 
and drawing on the concepts of validity and reliability238. The protocol for thematic analysis 
developed by Mays et al.239 was used to identify prominent or recurring themes, and to 
summarize the findings under thematic headings using summary tables238. The principles of 
grounded theory were also followed to constantly compare, contrast, synthesise and code data by 
theme and subsequently by thematic category, based on Charmaz240 and Clarke241. It was used to 
identify patterns in primary data, being an inductive approach to analysis, that allows the theory 
to emerge from the data. Data was then interpreted by a qualitative content analysis approach, 
based on Mayring242.  
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Coding was independently conducted by two researchers and disagreements in abstractions were 
discussed with a third researcher and resolved by consensus. Internal reliability and reflection were 
maximized though comparing coding between multiple researchers. 
3.4 Methodological issues 
Research on reproductive themes often deals with the main challenge of having the couple as unit 
of analysis, rather than an individual16, which involves methodological and ethical dilemmas in 
study design, participants’ recruitment, data collection, and analysis and interpretation of the data 
gathered. Qualitative studies show that being alone or in the presence of the partner shape the 
reporting of experiences and emotions243, 244; data collection may be affected when one person 
dominates the interview245, 246 ethical dilemmas may occur if tensions/disagreements happen 
between partners244, 245. Quantitative studies have focused on the preferential mode of 
questionnaire completion by women in infertility surveys247, the interaction and mutual influence 
of both members of the couple248, the heterogeneity across individuals249, and the strengths and 
weaknesses of the use of dyadic data analysis when the participant is a couple250.  
This thesis involved collecting quantitative and qualitative data with couples, alternating between 
sides over time, with a quantitative-dominant approach characterized by complementarity224, 251. 
The use of quantitative and qualitative methods aimed to maximize the understanding of the 
topic under research by looking for answers to different research questions in order to contribute 
to produce evidence to sustain the development of patient-centred policies and for ethics in 
clinical practice251. A quantitative approach was used to respond to the first two specific objectives 
of this thesis, while the third and fourth objectives claim for a mixed-methods and a qualitative 
approach, respectively.  
Protocols for qualitative data analysis were selected according to the objectives and 
methodological approaches of each manuscript. When analysing data related with the open-
ended questions included in the questionnaire and with the topic interview-guide question about 
the storage period for embryos, a protocol for content analysis216 that differs from more 
‘qualitative’ methods was chosen, because it relies on the systematic application of rules and 
draws on the concepts of validity and reliability217, in accordance with the quantitative approach 
used in the first three specific objectives of this thesis.  
When analysing the narratives enacted by IVF couples regarding their perception about the 
factors that contextualize informed consent in the field of embryo disposition, the grounded 
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theory240, 241 was used to identify patterns in primary data, based on an inductive analysis that 
allows the theory to emerge from the data.  
Taking into account the fact that the present study involved joint quantitative and qualitative 
interviews with couples, researchers were aware of the response effect or partner effect, which 
happens when interviewees change or hinder their answers as a result of the interview situation, 
by withholding information or changing presentation style, for example, even if it is 
unintentional245, 252. This process often boosts a greater agreement between the opinions of both 
partners on a variety of attitudinal and behavioural items253. Additionally, there were situations 
when one of the elements of the couple had a dominant attitude, by speaking most of the time, 
despite the attempts by the researcher to question the other directly and obtain his/her 
opinion244. This may affect the opinions of the other and the opportunity to express them245, 254.  
There is also the possibility that researchers have induced more reflexivity about the topic of 
embryo donation for research, and, thus, have also motivated participants to search for more 
information, with an influence on their attitudes and, eventually, on the decision to participate in 
the study at time 2. Although there is no evidence regarding the motivations to complete or not a 
second questionnaire, it could be hypothesized that those who most reflected on embryo 
donation for research were more motivated to remain in the study. This highlights the importance 
of considering ethics in practice243, emphasizing the ethical responsibility of the researchers to 
disseminate the results of the research among participants255. 
In this work, the fact that several women attended the medical appointment without their male 
partner raised two main concerns: was it helpful, from a basic research perspective, not having to 
exclude the women who went alone in a setting where they are available, and if so, were there 
differences in self-reporting of psychosocial variables when women or couples were recruited? To 
answer these questions, PAPER II was performed, with the objective of comparing the self-
reporting of sociodemographic and psychosocial characteristics by female IVF patients 
interviewed alone or with the partner in heterosexual couples. This study concluded that no 
statistically significant differences were found in the self-reporting of depression, anxiety, social 
support and partner relationship or in sociodemographic and obstetric characteristics between 
women interviewed alone or with the partner. Thus, having a male partner present in the research 
setting during a self-administered questionnaire seems not to influence women’s responses to 
psychosocial measures.  
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The development of evidence-based guidelines for conducting research on health conditions 
involving more than one person claims for studies assessing other outcomes and being 
conducted in other settings and sociocultural and economic contexts. It would be useful to assess 
the influence of differences in reproductive control and access to reproductive healthcare in a 
context of “stratified reproduction”256. Notwithstanding, these results contribute with important 
information that should be taken into account when planning studies on infertility and in the 
psychosocial assessment of IVF patients in clinical psychology practice. 
3.5 Ethics 
In data collection, storage, analysis and dissemination, procedures were developed in order to 
guarantee data confidentiality and protection. Ethics approval was granted by Ethics Committee 
for Health of the Centro Hospitalar de S. João. 
Patients were first approached by the nurses and given a study information sheet, with an 
explanation on the purposes and design of the study. One member of the research team then 
invited the potential participants to take part in the study, responding to all of their questions. 
Patients who decided to participate in the study were accompanied to a private room in the 
reproductive centre, where they read and signed the informed consent. All participants formalized 
their collaboration through a written informed consent form according to the World Medical 
Association’s Declaration of Helsinki. 
All materials were anonymous and confidential. Each participant was identified with a numerical 
code, in the questionnaires and in databases. Data protection was guaranteed in accordance with 
the usual rules of confidentiality and only the research team had access to the data. Personal data, 
consents, questionnaires, interview tapes and transcripts were coded and kept separately from 
one another in locked file cabinets. Audio files will be destroyed at the end of the study. Interview 
transcripts are archived at the Institute of Public Heath of the University of Porto for 5 years. Once 
archived, transcripts were subject to strict protection and were not available, unedited, to any 
second party. 
The interviewers were trained using a structured protocol addressing all the questionnaires’ 
queries and periodic supervision of their work was undertaken by a senior social sciences 
researcher. A multidisciplinary team, with experience in national and international projects, was 
responsible for the staff training and the development of the questionnaire and the interview 
guide. Transcription of the interviews was performed by a professional, reliable service with a strict 
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confidentiality policy in operation. Identifiable information was inevitably captured on the audio 
recordings but only the research team and transcription service had access to these files. 
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3.6. Paper II. Self-reported psychosocial factors among In Vitro 
Fertilization patients interviewed alone or with the partner 
Samorinha C, Fraga S, Alves E, Sousa S, Figueiredo B, Machado H, Silva S 
Psychology, Health & Medicine 2015; Nov 7:1-8.  
DOI: 10.1080/13548506.2015.1109672 [Epub ahead of print] 
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4.2 Paper IV. Couple’s willingness to donate embryos for 
research: a longitudinal study 
Samorinha C, Severo M, Machado H, Figueiredo B, de Freitas C, Silva S. 
Acta Obstetricia et Gynecologica Scandinavica 2016; Mar 21.  
DOI: 10.1111/aogs.12900. [Epub ahead of print]
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RESUMO 
A criopreservação de embriões é precedida da assinatura de um consentimento informado por 
parte dos usuários de técnicas de procriação medicamente assistida. Este estudo analisou as 
perceções de casais inférteis quanto aos fatores que contextualizam o consentimento livre e 
esclarecido na criopreservação de embriões. Explorou-se a provisão de cuidados de saúde 
                                                 
16 Esta pesquisa foi realizada com apoio financeiro de Fundos FEDER através do Programa Operacional Fatores de 
Competitividade - COMPETE e por Fundos Nacionais através da FCT - Fundação para a Ciência e a Tecnologia, no âmbito 
do projeto FCOMP-01-0124-FEDER-014453 (Ref.ª PTDC/CS-ECS/110220/2009), das bolsas Investigador FCT IF/00829/2013 
e IF/00956/2013, de uma bolsa de pós-doutoramento (SFRH/BPD/80530/2011) e de uma bolsa de doutoramento 
(SFRH/BD/75807/2011), cofinanciadas pelo Programa Operacional Potencial Humano (POPH). 
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centrados no paciente, com implicações para a prática clínica e a regulação. Realizaram-se, em 
2012, 34 entrevistas semiestruturadas a casais envolvidos em técnicas de Procriação Medicamente 
Assistida numa Unidade Pública de Medicina da Reprodução, em Portugal. Procedeu-se à análise 
dos dados segundo os princípios da teoria fundamentada. Os resultados revelaram uma perceção 
do consentimento como um formalismo, que é assinado num momento inadequado e muitas 
vezes aplicado por profissionais não qualificados. Emergiram as seguintes necessidades: provisão 
atempada de informações detalhadas, rigorosas e coerentes sobre os custos e a duração máxima 
da criopreservação e o destino efetivo dos embriões; reforço da privacidade física; dispor de 
tempo para refletir sobre o destino dos embriões e sobre a divulgação da identidade dos 
beneficiários. As condições em que o consentimento foi aplicado parecem ameaçar três 
elementos fundamentais do consentimento - informação, voluntarismo e ponderação. Importa 
desenvolver orientações profissionais e éticas que assegurem a prestação de um consentimento 
assente em práticas de aconselhamento e de prestação de informação adequadas às necessidades 
e expectativas dos pacientes. 
 
Palavras-chave - Consentimento esclarecido; criopreservação; assistência centrada no paciente; 
fertilização in vitro; destinação do embrião. 
 
Consenting on embryo cryopreservation: perception of infertile couples 
 
ABSTRACT 
Cryopreservation of embryos is preceded by the signature of an informed consent by those 
benefiting from assisted reproductive technologies. This study analysed infertile couples’ 
perceptions of the factors that contextualize informed consent regarding embryo 
cryopreservation. Patient-centred care delivery was also explored with implications for clinical 
practice and regulation. In 2012, 34 semi-structured interviews were conducted with couples 
involved in Assisted Reproductive Technologies at a public reproductive medicine unit, in 
Portugal. Data were analysed according to the principles of grounded theory. Data gathered 
revealed a perception of informed consent as a mere formality, signed in inadequate period of 
time and often administered by non-qualified professionals. The following needs have been 
identified: timely provision of detailed, accurate and intelligible information about the costs of 
cryopreservation, embryo storage limit and effective embryo disposition; reinforcement of 
physical privacy; availability of time to reflect about embryo disposition and the disclosure of 
users’ identities. The conditions under which the informed consent was administered appear to 
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threaten three fundamental elements of the consent - information, voluntarism and reflection. It is 
necessary to develop professional and ethical guidelines that can ensure the implementation of a 
consent process characterized by practices of advice and information adapted to patients’ needs 
and expectations. 
 
Keywords - Informed consent; cryopreservation; patient-centered care; fertilization in vitro. 
 
INTRODUÇÃO 
A criopreservação de embriões é, na maioria dos países, acompanhada da assinatura de um 
consentimento informado por parte de usuários de técnicas de procriação medicamente assistida 
(Ory e col., 2013; Leite e Henriques, 2014). Em Portugal, o modelo de consentimento informado é 
aprovado e revisto pelo Conselho Nacional de Procriação Medicamente Assistida (Portugal, 2013), 
e inclui informações sobre os benefícios, riscos e limitações da criopreservação de embriões e 
menciona a duração máxima da criopreservação (3 anos) e os destinos dos embriões 
criopreservados - utilização pelo casal, doação para outros casais inférteis, doação para 
investigação e destruição.  
O consentimento é assinado pelo/a médico/a e pelo casal beneficiário, sendo passível de 
revogação por qualquer um dos membros do casal. O casal formaliza a decisão quanto ao destino 
dos seus embriões criopreservados e à divulgação da sua identidade nas situações legalmente 
previstas ao escrever “sim” ou “não” à frente das seguintes afirmações: “consentimos no uso dos 
nossos embriões para doação a outros casais inférteis”; “consentimos no uso dos nossos embriões 
em projetos de investigação científica”; e “autorizamos que o Conselho Nacional de Procriação 
Medicamente Assistida divulgue as nossas identidades, nos casos excecionalmente previstos no 
n.º 3 do artigo 15.º da Lei n.º 32/2006 de 26 de julho”, ou seja, quando as pessoas nascidas em 
consequência da dádiva de embriões solicitem informações que lhes digam respeito para 
averiguar eventual existência de impedimento legal a projetado casamento.  
A decisão sobre o destino dos embriões criopreservados é particularmente desafiadora e difícil 
(Fasoulitis e Schenker, 1996; Autor, 2014a). A possibilidade de doar embriões pode ser 
enquadrada numa ética de solidariedade e altruísmo e perspetivada como um contributo para o 
desenvolvimento científico ou para a saúde e bem-estar de casais inférteis ou da população em 
geral (Autor, 2013b; Autor, 2014a). No entanto, esta hipótese também pode originar 
preocupações quanto à proteção e estatuto do embrião criopreservados (Fasoulitis e Schenker, 
1996; Schuster e col., 2003; Haimes e col., 2008), discordância entre os membros do casal 
(Hammarberg e Tinney, 2006) e, ainda, questionar a confiança depositada nos médicos ou 
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investigadores, por escassez de informação e/ou de aconselhamento (Autor, 2013a; Lyerly e col, 
2006). Neste contexto, há casais que tentam prolongar a criopreservação, adiando a decisão em 
relação ao destino dos embriões criopreservados (de Lacey, 2005) enquanto sentem inconstância 
nas suas preferências (Lyerly e col., 2006).  
A obtenção do consentimento pode consubstanciar uma estratégia de humanização, 
democratização, prestação de contas e transparência de processos e decisões (O’Neill, 2004) ao 
favorecer o diálogo entre profissionais de saúde e beneficiários (WHO, 2007) e ao proporcionar 
uma reflexão sobre a criopreservação por parte de todos os atores envolvidos. No entanto, pode 
também reduzir-se a uma formalidade ou revelar-se uma prática problemática ao transferir 
responsabilidades complexas para o casal (Menegon, 2004; Autor, 2008, 2014b). Globalmente, 
importa que o consentimento seja informado/esclarecido (o que exige a compreensão do 
respetivo conteúdo e das informações orais e escritas facultadas adicionalmente), voluntário (sem 
qualquer tipo de pressão ou coação, externa ou interna, na tomada de decisão) e ponderado 
(precedido de tempo para refletir), elementos especialmente relevantes quando o processo de 
decisão passa pela procura de consenso entre os elementos do casal (Entidade Reguladora da 
Saúde, 2009; Consumers Health Forum of Australia, 2013). 
Assegurar a qualidade das práticas que envolvem a prestação do consentimento para a 
criopreservação de embriões afigura-se, assim, como um elemento central na provisão de 
cuidados centrados no paciente, ou seja, cuidados respeitadores e responsivos às necessidades, 
valores e preferências dos casais (Institute of Medicine, 2001; Fortes, 2004). Para esse efeito, 
importa conhecer as perspetivas dos beneficiários quanto aos fatores organizacionais (por 
exemplo, provisão de informação, competência, coordenação e integração dos profissionais de 
saúde, conforto físico e acessibilidade) e humanos (entre outros, atitude e relação com os 
profissionais de saúde, comunicação, envolvimento dos pacientes, privacidade e suporte 
emocional) que contextualizam o consentimento (Mourad e col., 2010; Dancet e col., 2012). Este 
conhecimento é relevante considerando a ausência de orientações e de guias de prática clínica, 
em Portugal, com indicações sobre as circunstâncias em que o consentimento deve ser entregue, 
explicado e assinado (Leite e col., 2014).  
No entanto, a escassa literatura sobre as visões dos usuários em torno da criopreservação de 
embriões tem descurado a análise do consentimento informado, focalizando a atenção nas 
perceções sobre a segurança dos procedimentos envolvidos na criopreservação e repercussões na 
viabilidade e qualidade dos embriões e na eficácia dos tratamentos (Bankowsky e col., 2005; 
Provoost e col., 2010), nas opiniões sobre a duração máxima da criopreservação (Autor, 2015), e 
nos fatores que influenciam o processo de decisão quanto ao destino dos embriões 
criopreservados (Autor, 2014a).  
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Neste artigo, a análise das perceções de casais inférteis sobre o consentimento informado para 
a criopreservação de embriões servirá de mote para refletir sobre reconfigurações na prática 
clínica e respetiva regulação, enquadradas na provisão de cuidados de saúde centrados no 
paciente. 
 
MÉTODOS 
Entre 17 de agosto de 2011 e 16 de agosto de 2012, todas as mulheres e homens que recorreram 
a Fertilização In Vitro ou Injeção Intracitoplasmática de Espermatozoides numa Unidade Pública 
de Medicina da Reprodução, em Portugal, foram convidados a participar num estudo sobre as 
decisões dos casais em torno do destino dos embriões, aprovado pela Comissão de Ética para a 
Saúde do Centro Hospitalar de S. João, EPE. Aplicou-se um questionário no dia em que realizaram 
o exame para confirmar uma eventual gravidez e, nessa altura, solicitou-se autorização para 
estabelecer um contato posterior, após 3/4 meses, no sentido de serem entrevistados.  
Com base nos participantes que aceitaram ser contatados para agendar uma entrevista, 
constituiu-se uma amostra intencional, considerando a inclusão de casais com diferentes decisões 
em relação à doação de embriões para investigação científica (aceitação versus recusa) e com 
estatutos parentais diferenciados (gravidez versus não gravidez). Entre fevereiro e novembro de 
2012 convidaram-se 56 casais para participar numa entrevista semiestruturada, 22 dos quais 
recusaram (13 não mencionaram o motivo, 4 alegaram falta de disponibilidade, 3 referiram 
obstáculos emocionais, 1 invocou doença e 1 casal reportou estar separado). Foram assim 
realizadas 34 entrevistas em casal, conduzidas pela mesma entrevistadora. As características dos 
entrevistados encontram-se descritas na Tabela 1. 
Todos os casais formalizaram a sua colaboração através da assinatura de um consentimento 
informado, de acordo com a Declaração de Helsínquia da Associação Médica Mundial, em 
situação de copresença física. As entrevistas, com uma duração média de 81 minutos (mínimo-
máximo: 62-111 minutos), aconteceram nas instalações das instituições de acolhimento do 
projeto (n=16), em casa (n=17) ou no local de trabalho dos participantes (n=1), entre março e 
dezembro de 2012. Todas as entrevistas foram gravadas com autorização dos participantes e 
integralmente transcritas, sendo a qualidade das transcrições verificada pela equipa de 
investigação. 
Neste artigo analisam-se as respostas às seguintes questões: Vocês assinaram um consentimento 
onde declararam a vossa decisão sobre o destino dos embriões. Podem falar-me um pouco desse 
momento? Como reagiram? O que sentiram? Alguém vos informou ou aconselhou nesse 
processo? De que forma?  
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As respostas obtidas foram sistematicamente comparadas, sintetizadas e codificadas por 
temas e por categorias, de acordo com os princípios da teoria fundamentada (Clarke, 2005; 
Charmaz, 2006). A análise de conteúdo e a interpretação dos resultados basearam-se numa 
abordagem qualitativa (Mayring, 2004), explorando a provisão de cuidados de saúde centrados 
no paciente (Mourad e col., 2010; Dancet e col., 2012) através da dissecação de um conjunto 
selecionado de extratos ilustrativos das perceções dos casais entrevistados em torno do 
consentimento informado na criopreservação de embriões. Os dados foram analisados por dois 
investigadores independentes e todas as dúvidas foram resolvidas por discussão conjunta até se 
obter consenso. Utilizou-se o NVivo 10 nesta análise. 
 
RESULTADOS 
No discurso dos entrevistados prevaleceu a perceção do consentimento como um formalismo, 
diluído em memórias associadas a outras fases do tratamento. Destacou-se a inadequação do 
momento em que o consentimento é assinado (após a transferência de embriões, quando 
imperavam outras preocupações associadas ao sucesso do tratamento) e a escolha de 
profissionais não qualificados para o entregar. Os casais realçaram a necessidade de investir nos 
seguintes aspetos: provisão atempada de informações detalhadas, rigorosas e coerentes sobre os 
custos e a duração máxima da criopreservação e os destinos dos embriões criopreservados; 
reforço da privacidade física; e dispor de tempo para refletir sobre as suas decisões quanto ao 
destino dos embriões criopreservados e à divulgação da identidade do casal. Estas condições 
parecem ameaçar elementos fundamentais do consentimento – informação, voluntarismo e 
ponderação, como se mostrará de seguida. 
 
Um formalismo (sem) sentido 
A perceção de que o consentimento constituiu um instrumento formal, diluído num conjunto de 
memórias associadas a outras fases do tratamento, foi dominante nas narrativas dos 
entrevistados. Estes utilizaram frequentemente expressões como “papéis”, “papelada”, “folhinha”, 
“questionário” e “documentos” para se referirem ao consentimento, situando de forma difusa a sua 
assinatura entre “os momentos vários em que lá vamos [ao centro de PMA]” [E34]. Anabela, por 
exemplo, perspetivou o consentimento como “mais um formulário”, enquadrando a sua opinião 
na falta de informação detalhada sobre o mesmo e no tempo que esperou para ser atendida: 
 
Anabela - Não houve uma informação detalhada e (…) as pessoas estão ali (…) três horas à 
espera. (…) Salvo as pessoas que estejam mais sensibilizadas e que até tenham algum 
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conhecimento de causa, [as outras preenchem o consentimento como] mais um formulário. 
[E6] 
 
Um dos fatores que, na perspetiva dos entrevistados, contribui para a concetualização do 
consentimento como uma formalidade é a inadequação do momento em que é assinado. A 
grande maioria mencionou ter assinado o consentimento “à toa”, “em cima do joelho” ou “à 
pressa”, após a transferência de embriões, num contexto de relativa sonolência e desgaste – “uma 
altura em que eu estava ainda (…) meia abananada” [E5] – e onde imperavam outras 
preocupações, como assegurar a maximização da probabilidade de confirmar uma gravidez. Os 
relatos seguintes alertam para a necessidade de considerar um eventual estado de dissonância 
cognitiva e/ou afetiva dos casais na definição do momento adequado para assinar o 
consentimento sobre a criopreservação de embriões (Lyerly e col., 2006), ao evidenciar como o 
foco no sucesso do tratamento (Kato e Sleebom-Faulkner, 2011) não favorece a reflexão nem a 
decisão autónoma sobre questões que não visem diretamente o alcance da gravidez: 
 
Rita – Ali foi uma pressão: assinem, leiam, assinem! E uma pessoa está tão focada na 
gravidez, quer um bebé... [E29] 
 
Mónica - Foi uma época um bocadinho complicada para mim, porque eu tinha tanta coisa 
na cabeça que, realmente, quando [os profissionais de saúde] me diziam para assinar [um 
documento] eu era quase de cruz.  
Nilton - Sim, é verdade! [E33] 
 
Maurício - Agora, que as coisas já estão bem encaminhadas [gravidez confirmada], acho 
que temos outra disponibilidade para pensar sobre o assunto e, com clareza, dizer o que é 
que queríamos e o que é que gostávamos em função daquilo que sabemos ou que nos 
informaram. [E1] 
 
Também a escolha de profissionais não qualificados para aplicar o consentimento sustentou a 
perceção de que este se reduz a um instrumento formal. De acordo com as situações relatadas 
pelos entrevistados, tal tarefa coube maioritariamente à rececionista e muito raramente a 
biólogos. A maioria dos casais enquadrou a delegação da entrega do consentimento a um 
profissional menos qualificado na falta de tempo dos médicos para o fazer, devido ao excesso de 
trabalho. O recurso a este argumento coexistiu com o reconhecimento da ausência de 
competências dos profissionais administrativos para proporcionar informações adicionais e 
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esclarecer dúvidas específicas sobre o conteúdo do consentimento, como ilustra o diálogo 
estabelecido entre Nicolau e Rosana.  
 
Nicolau - A rececionista não foi, de maneira nenhuma, mal-educada nem nada dessas 
coisas, nem [nos] despachou. (…) Só que ela tem sempre muita coisa que fazer e pode haver 
certas coisas que…  
Rosana - Há coisas que ela não consegue explicar, não é? [E22] 
 
Os entrevistados alertaram para a necessidade de contemplar tais competências na 
definição do perfil adequado dos profissionais responsáveis pela aplicação do 
consentimento sobre a criopreservação dos embriões, independentemente do grupo 
profissional que o faça - médicos, enfermeiros, biólogos ou embriologistas.     
 
Experiências em torno da provisão de informação 
Os entrevistados salientaram a necessidade de investir na provisão atempada de informações 
detalhadas sobre os seguintes tópicos: 1) quem suporta os custos financeiros da criopreservação 
e qual o montante; 2) vantagens e desvantagens associadas aos diferentes destinos dos embriões 
criopreservados, nomeadamente informações adicionais sobre os projetos de investigação que os 
pretendem utilizar e sobre a eventual ocorrência de nascimentos de embriões doados a outros 
casais, assim como sobre o destino efetivo dos embriões doados; 3) possibilidade de poder alterar 
as decisões formalizadas no consentimento. Mariana, por exemplo, preocupou-se em esclarecer o 
destino efetivo dos embriões após os três anos de criopreservação, indagando a possibilidade de 
os embriões serem eliminados:   
 
Mariana - A minha pergunta foi: E passados os dois anos ou três (…) deitam fora? (…) Eles 
[profissionais de saúde] disseram: “Não, (…) se quiser continuar com eles criopreservados é 
só informar-nos que continuam”. [E1] 
 
A informação oral sobre a oportunidade de prolongar a criopreservação para além do período 
legalmente previsto, com base na simples solicitação do casal, contraria a seguinte informação 
escrita no consentimento: “Compreendemos que, de acordo com a legislação em vigor, os 
embriões serão conservados por um período máximo de três anos e que, decorrido este prazo, se 
os embriões não tiverem sido por nós utilizados ou não lhes tiver sido dada outra utilização por 
nós consentida, serão descongelados e eliminados”. Também o relato de Antónia evidencia 
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contradições no esclarecimento de dúvidas acerca dos custos financeiros a suportar pelo casal no 
âmbito da criopreservação: 
 
Antónia – Lemos [o consentimento] (…) e perguntamos: “Olhe, ninguém nos informou sobre 
os custos. Qual é o custo?”. E a senhora [rececionista] também não sabia dizer e foi 
perguntar ao enfermeiro, que depois acabou por dar a resposta errada. Nós depois tivemos 
que pagar (…), mas a resposta que nos deram era que não haveria custos. (…) Não sei se foi 
20€, se foi 25€ por cada um [embrião] que pagamos. Mas eu depois ainda perguntei: “Mas 
isso é por ano ou é para os três anos?”. Não me sabiam dizer! [E13] 
 
Estas situações alertam para a importância de assegurar o rigor e a qualidade das informações 
prestadas pelos profissionais de saúde, elementos que facilitam a obtenção de consenso entre os 
elementos do casal e têm sido associados à diminuição dos seus níveis de ansiedade (de Lacey, 
2005; Hammarberg e Tinney, 2006; Lyerly e col., 2006). O investimento no reforço da informação é 
especialmente relevante num contexto em que a maioria dos entrevistados realçou a confiança 
depositada em todos os profissionais que os acompanharam, ainda que elegessem os médicos e, 
esporadicamente, os biólogos como os profissionais melhor posicionados para prestar 
informações no âmbito da criopreservação de embriões - “um médico ou um biólogo; quem esteja 
dentro [do assunto]” [E27]. 
A otimização da prestação de um consentimento na criopreservação de embriões passa, na 
perspetiva dos entrevistados, por um processo bidirecional contínuo e dinâmico que envolve, 
simultaneamente, os casais e os profissionais de saúde, em particular o/a médico/a responsável 
pela assinatura do consentimento. O acesso a informação pormenorizada e coerente surgiu 
frequentemente articulado com a necessidade de promover a disponibilidade, solicitude e 
sensibilidade dos profissionais de saúde para: explicar conteúdos de natureza técnica e científica; 
esclarecer dúvidas; e proporcionar aconselhamento no processo de decisão em torno das 
questões colocadas no consentimento (o destino dos embriões criopreservados e a divulgação da 
identidade dos beneficiários nos casos legalmente previstos). Estes processos ocorrerão, 
sobretudo, nos casos em que os casais sentem tais necessidades e deverão respeitar a liberdade 
das escolhas individuais: 
 
Maurício – Eu, agora que volto atrás, digo que o facto de não ser apoiada a decisão permite 
total anonimato e liberdade aos decisores, que somos nós, de tomarem a sua decisão. [E1] 
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Os entrevistados também salientaram a sua própria responsabilidade na procura ativa de 
informações, questionando diretamente os profissionais de saúde e/ou utilizando diversas fontes 
de informação (por exemplo, internet e folhetos disponíveis em diversos centros), existindo casais 
que se culpabilizaram por não o ter feito: 
 
Mariana - Se nós tivéssemos mais perguntas para fazer, de certeza que [os profissionais de 
saúde] nos respondiam. [E1] 
 
Rita – Realmente, nós somos uns inconscientes! Devíamos ter pensado nisto [decisão em 
torno do destino dos embriões criopreservados], devíamos ter falado disto em casa os dois. 
Joel - Bom, eu não senti que fossemos inconscientes. A questão é que teria sido, de facto, 
melhor. [E29] 
 
O papel da privacidade física 
Nas narrativas dos entrevistados emergiu a necessidade de reforçar a privacidade física no 
contexto da assinatura do consentimento, ou seja, o direito do casal a estar sozinho ou num 
espaço físico com acessibilidade limitada. A maioria dos casais manifestou “incómodo” ou 
“desconforto” por ter assinado o consentimento na sala de espera, diante de outras pessoas e 
muitas vezes a pé e junto ao balcão de atendimento, local de passagem obrigatória para aceder à 
porta que dá acesso aos consultórios, gabinetes e salas de exame: 
 
António – [Assinei o consentimento] Na receção, depois de ter estado quatro horas à espera 
e já com outras pessoas ali que estavam a ser chamadas, e têm que passar por aquele 
guiché para entrar. Portanto, sem condições, com poucas, com fracas condições para poder 
tomar uma decisão. [E6] 
 
Rita - Estarmos ali os dois ao balcão a falar [sobre a nossa decisão]… Imagine o que é uma 
sala cheia de gente: aquela sala é pequenina, uma pessoa tem os bancos, mas está sempre 
cheia, e estamos ali a assinar! (…) Pois, eu nem me senti bem! [E29] 
 
Alguns casais referiram ter saído da sala de espera para ler e assinar o consentimento num 
espaço público imediatamente contíguo, junto aos elevadores, com o objetivo de conquistar 
alguma reserva e recolhimento enquanto dialogavam sobre as decisões a tomar: “Fomos para 
junto dos elevadores para falarmos um bocadinho, mas foi uma coisa de dois minutos” [Carina, E9]. 
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Avaliação do tempo para refletir 
De acordo com os entrevistados, o tempo proporcionado para refletir sobre o consentimento 
informado foi escasso, considerando a sensibilidade das questões colocadas sobre o destino dos 
embriões criopreservados e sobre a divulgação da identidade dos beneficiários, assim como as 
eventuais dificuldades associadas à procura de consenso entre os membros do casal. 
 
Rita - Não foi uma coisa [assinar o consentimento] muito refletida. 
Joel - Sim. Com essa formalidade de termos objetivamente ali aquilo apresentado, falarmos 
sobre qual é que ia ser a nossa decisão e de pensarmos um bocadinho o que é que 
queríamos. [E29] 
 
Horácio - Eu acho que é um tema muito delicado e não pode ser pensado nem decidido 
logo na hora. Devíamos ter mais tempo (…) e tirarmos as nossas dúvidas. [E23] 
 
Alguns entrevistados sugeriram abrir a possibilidade de levar o consentimento para casa antes 
de o assinarem, maximizando desta forma o tempo de reflexão, discussão e eventual 
aconselhamento. Marco, por exemplo, mencionou não ter sentido dificuldades em assinar o 
consentimento de imediato, mas reconheceu que outras pessoas poderão necessitar de mais 
tempo para solidificar o processo de tomada de decisão:   
 
Marco – [Para nós] Foi fácil [decidir de imediato], mas acho que há pessoas que ficam ali a 
pensar se estão a tomar uma decisão correta ou não. Se calhar, queriam voltar para casa, 
aconselhar-se com alguém. (…) Aí as decisões seriam mais sólidas, mais seguras. [E3] 
  
De fato, a maioria dos entrevistados recordou a “surpresa” que sentiu perante a solicitação da 
assinatura do consentimento informado - “foi uma surpresa, porque nunca achei que fosse ali 
naquela hora, sem apoio, sem mais explicações. Por isso é que, entretanto, acho que já mudei de 
ideias” [E32]. As suas narrativas expressam, frequentemente, a necessidade de dispor de mais 
tempo para refletir, o que possibilitaria uma melhor gestão das emoções e mais certeza e 
segurança nas decisões a tomar:     
 
Daniela - Mas quando se começa a ler [o consentimento]… 
Manuel - Assusta! 
146   |   Embryo donation for research: a patient-centred approach 
 
Daniela - Assusta, assusta! (…) É a decisão sobre aquilo que pode ser, na minha conceção, 
um ser humano. [E7] 
 
Américo - Fui eu que preenchi o papel [consentimento] e assinalei sim nos dois casos 
[doação para outros casais e doação para investigação científica]. Mas depois, quando dei [à 
companheira] para assinar, ela leu melhor (…) e começou a chorar. (…) E depois foi pedir o 
papel novamente [à secretária] para alterar a decisão para [não doar a outros] casais. [E30] 
 
Leandro - Eu realmente não pensei muito naquele momento. (…) 
Sónia - Eu já tinha posto a cruz e ele só assinou. (…)  
Leandro – Concordei [com a decisão dela]. Fui um bocado empurrado a concordar, mas 
concordei. [E4] 
 
DISCUSSÃO 
As perceções de casais inférteis sobre as práticas que envolvem o consentimento informado para 
a criopreservação de embriões convidam a refletir sobre três dimensões centrais na provisão de 
cuidados de saúde centrados no paciente, com implicações para a prática clínica e para a 
regulação.  
Primeiro, este estudo salienta a necessidade de investir no desenvolvimento de orientações 
que regulem o momento da entrega e da assinatura do consentimento informado, assim como o 
perfil dos profissionais de saúde com competência e qualificações para acompanhar os casais 
nessas situações. Ainda que alguns países prevejam a assinatura do consentimento antes do 
primeiro tratamento (Pennings, 2007), durante o tratamento (Bjuresten e Hovatta, 2003) ou após a 
conclusão do tratamento (Ethics Commitee of American Society for Reproductive Medicine, 2014), 
não existe estandardização deste procedimento entre países e a legislação é omissa a este 
respeito em Portugal. Na definição desses momentos importa considerar as trajetórias 
reprodutivas dos casais e proporcionar-lhes tempo para refletir sobre as decisões a tomar. 
Estudos prévios mostram que o nascimento de um filho pode estar associado a uma mudança na 
decisão em relação ao destino dos embriões criopreservados (Hammarberg e Tinney, 2006), tendo 
em conta que a perspetiva dos casais sobre o simbolismo atribuído ao embrião criopreservado 
muda, tornando-se este uma “criança virtual” (de Lacey, 2005). Neste sentido, o pedido do 
consentimento numa altura em que, para os casais, ainda não é evidente se os seus embriões 
serão “excedentários”, pode pôr em causa a tomada de decisão consciente e a qualidade do 
consentimento informado (Scott e col., 2012).  
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Os resultados obtidos evidenciam, ainda, a necessidade de providenciar atempadamente 
informações precisas e detalhadas sobre a duração máxima da criopreservação de embriões e os 
custos financeiros envolvidos nesse procedimento (Autor, 2015) e sobre os destinos efetivos dos 
embriões criopreservados. Importa clarificar, em especial, os objetivos dos projetos de 
investigação que pretendem usar os embriões (Autor, 2013b), como recomendado pelo Ethics 
Commitee of American Society for Reproductive Medicine (2014), num contexto em que a falta de 
informação é um dos aspetos apontados pelos pacientes como tendo tido mais influência na sua 
decisão (Lyerly e col., 2006; Silvestre, 2015). Além disso, a informação sobre as circunstâncias em 
que pode ocorrer o descongelamento e a destruição dos embriões, bem como sobre os moldes 
em que os casais podem alterar as decisões formalizadas no consentimento informado, constitui 
um direito fundamental dos pacientes (Nelson, 2008). Importa assegurar a coerência, rigor e 
qualidade das informações prestadas pelos profissionais de saúde e treinar as respetivas 
competências comunicacionais para esclarecer dúvidas e aconselhar os casais que manifestem tais 
necessidades, potenciando uma comunicação efetiva entre médicos e pacientes (Institute of 
Medicine, 2001) e a prestação de cuidados centrados no paciente.  
Este estudo mostra, por último, a importância de reforçar a privacidade física no âmbito da 
assinatura do consentimento. A existência de espaços físicos confortáveis e com acesso limitado é 
fundamental, para que cada casal possa expressar as suas sensações e as respetivas decisões de 
forma autónoma e privada.  
A prática de um consentimento informado que potencie o fornecimento de cuidados de saúde 
centrados no paciente requer que os vários aspetos que contextualizam este procedimento sejam 
atendidos. Considerando que a comunicação é particularmente difícil em situações que podem 
causar distress, moral e emocional (de Lacey, 2005; Hammarberg e Tinney, 2006), e que a tomada 
de decisão dos casais no contexto do consentimento informado na criopreservação de embriões é 
fortemente influenciada pelo aconselhamento (Shehab e col., 2008), importa disponibilizar o apoio 
de profissionais qualificados e devidamente treinados (Doyal, 2001) e também de grupos de pares 
(Soini, 2006) para minimizar a ocorrência de conflitos decisionais. Os profissionais são 
responsáveis por explicar conteúdos baseados na evidência e devem respeitar a liberdade de 
decisão dos casais (Soini, 2006), convidando-os a expressar as suas preferências e necessidades 
(Charles e col., 1999). Já o apoio dos pares contribui para atenuar sentimentos de isolamento e 
estigmatização e potencia o acesso a informações enraizadas em experiências comuns (Shehab e 
col., 2008). 
Constituindo um importante contributo para a reflexão sobre reconfigurações na prática clínica 
e regulação em torno do consentimento informado para a criopreservação de embriões, importa 
ter em conta que estes resultados são válidos no contexto em que foram recolhidos, devendo ser 
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analisados como um estudo de caso que procurou compreender e explorar a perspetiva de casais 
inférteis sobre este tema.   
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Tabela 1. Características dos casais entrevistados 
Entrevista* Pseudónimos Idades 
Níveis de 
escolaridade 
Doação de embriões 
para investigação 
Gravidez 
E1 Mariana e Maurício 28 e 27 Licenciada e 12º ano Sim Sim 
E2 Andreia e Amaro 36 e 28 Licenciados Sim Sim 
E3 Sandra e Marco 34 e 40 Bacharel e 12º ano Sim Sim 
E4 Sónia e Leandro 37 e 41 Bacharel e Licenciado Sim Não 
E5 Joana e Jorge 38 e 36 Licenciados Sim Não 
E6 Anabela e António 35 e 43 Mestre e Licenciado Não Não 
E7 Daniela e Manuel 35 e 38 Licenciados Sim Sim 
E8 Isabel e Tomás 33 e 33 12º ano e 9º ano Sim Sim 
E9 Carina e Rui 38 e 39 Licenciada e 12º ano Sim Não 
E10 Carolina e Miguel 25 e 30 12º ano e 9º ano Sim Não 
E11 Camila e Augusto 26 e 29 6º ano Sim Não 
E12 Sara e Fausto 37 e 35 6º ano Não Não 
E13 Antónia e Adalberto 31 e 36 Licenciada e 12º ano Sim Sim 
E14 Ana Maria e Roberto 27 e 34 6º ano Sim Não 
E15 Sílvia e Mariano 40 e 37 9º ano e 12º ano Sim Não 
E16 Dalila e Jaime 34 e 36 Licenciada e Bacharel Sim Não 
E17 Aurélia e André 36 e 36 Licenciados Sim Não 
E18 Maria e Cláudio 33 e 32 9º ano e 6º ano Sim Sim 
E19 Madalena e Josué 38 e 35 Licenciados Não Não 
E20 Cátia e Justino 39 e 42 Mestre e Licenciado Sim Sim 
E21 Manuela e Gustavo 38 e 38 Licenciados Sim Não 
E22 Rosana e Nicolau 30 e 40 Licenciados Sim Sim 
E23 Soraia e Horácio 37 e 40 6º ano e 12º ano Não Sim 
E24 Idalina e Nelson 38 e 35 12º ano Não Sim 
E25 Ana e Moisés 26 e 33 6º ano Sim Não 
E26 Ivone e Rogério 34 e 33 Licenciados Não Sim 
E27 Patrícia e Ernesto 37 e 41 Licenciada e Mestre Não Não 
E28 Tanya e Denys 38 e 34 12º ano Não Sim 
E29 Rita e Joel 33 e 33 Licenciados Sim Sim 
E30 Célia e Américo 35 e 46 12º ano Sim Sim 
E31 Laurinda e Hernâni 39 e 39 12º ano e Licenciado Não Sim 
E32 Erica e Daniel 34 e 35 Licenciados Sim Não 
E33 Mónica e Nilton 36 e 38 Licenciada e Mestre Sim Não 
E34 Eugénia e Marcos 32 e 34 Licenciada e Mestre Sim Não 
* Os participantes são descritos na tabela pela ordem de realização das entrevistas; no código alfanumérico atribuído a 
cada casal, os algarismos correspondem ao número de ordem da entrevista.  
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This observational and longitudinal mixed-methods study provided evidence to sustain the 
development of patient-centredness on embryo donation for research, with implications for 
clinical practice and regulation. Looking at patient-centred care through the lens of public health, 
this study contributes to advance knowledge in three key areas: openness and information about 
research with human embryos; suitability of research projects using cryopreserved embryos; 
policies and guidelines regarding informed consent process on embryo donation for research. Its 
innovativeness also relies on the assessment of psychosocial variables as anxiety, depression and 
quality of partner relationship, and the inclusion of both members of the couple, considering that 
these methodological features are absent from most of the studies on embryo disposition219.  The 
high response rate at baseline, with the use of a consecutive and systematic recruitment strategy 
in the largest centre in the Northern region of Portugal, emerged as an additional strength of this 
project. 
Regarding openness about research with human embryos, achievements from this study revealed 
a high receptivity to scientific and technological progress and trust in medical institutions and 
their professionals. More than three quarters of patients in this study were willing to donate 
embryos for research. This positive attitude was reinforced by the fact that none of the couples 
considered research on human embryos to be of slight importance. The high perceived value of 
embryo research is consistent with the changing social context in which legislation in several 
countries allows and regulates the use of human embryos in research88, and with previous studies 
conducted in Portugal that show how would-be-parents’ assessment of the benefits and risks of 
ART are imbued with hope, trust,  altruism, and receptivity to progress6, 114, 257.  
This framework is translated into the reasons invoked by IVF patients for donating embryos to 
research in this study, which are aligned with findings from other studies: willingness to contribute 
to scientific progress in general83, 258, to the development of IVF treatments in particular216, 259 and 
to the improvement of human health83, 260. These motives may also reflect the perception that 
minimal risks are associated with human embryo research, as mentioned by Priest et al.140, which 
contrasts with the report of fears by patients who were unwilling to donate embryos for research. 
Consistent with results obtained in previous studies83, 216, 258, 261, participants who were willing to 
donate embryos for research in our study also revealed a “sense of gratitude” to science and an 
“altruistic desire” to help others. These feelings, predominantly reciprocity, solidarity and altruism, 
might be simultaneously driven by external constraints and internal motivations, which have been 
previously described in the donation of biological material in Portugal257, 262. This socioethical 
framework redefines human embryos as a gift for the common good in the context of embryo 
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disposition263, 264, pointing to the conceptualization of embryo donation for research as an act of 
individual responsibility to contribute to the collective good and wellbeing265.  
IVF patients’ willingness to donate embryos for research should also be framed in the context of 
the setting where this study occurred - a public reproductive medicine centre located in a 
university hospital. The prevalence of embryo donation for research may be overestimated in this 
setting, as trust in the medical professionals, one of the key issues influencing the process of 
decision-making103, tended to increase when research is conducted in universities compared with 
the private sector142, 266.  It calls attention to the need of promoting an in-depth analysis of the 
relational and interactional aspects involved in the informed consent103, including the 
understanding of changes over time due to fluctuations on the information exchanged with the 
health professionals, to variations on the social network or in the reproductive trajectories of 
patients, among other factors80, 87. 
Data provided by this study was also important to deconstruct ideas regarding the influence of 
being Catholic on embryo donation for research. The majority of the Catholics were willing to 
donate embryos for research. Religious beliefs and the understanding of scientific facts and 
methods are not mutually exclusive and can coexist, with religion as a ‘perceptual filter’ that 
moderates the ways in which scientific knowledge affects attitudes267. In fact, the perspective 
associated with Catholic religion that human life begins at conception268 was also observed in 
participants’ reasons for not donating embryos for research. However, at the same time, this 
perception may also increase the value of an embryo, which can justify their use in research, as 
presented by de Lacey et al.269 and Provoost et al.260. Patients’ preference is justified by the idea 
that remaining embryos can “be used in a way”259. Thus, the meanings of the moral status of 
embryos seem to be varied and context-dependent, not fixed entities82, 270, with couples using a 
complex and dynamic system of embryo classification271. IVF patients perceive embryos 
simultaneously as epistemic or medical objects for research and clinical practices, and ontological 
objects for reproduction219, with an instrumental value260 that should not be wasted217, 272. 
Regarding information, this study showed that patients felt fears about what could happen to the 
embryos, and frequently mentioned having lack of information about research on human 
embryos, namely regarding the specific projects for which they were donating their embryos, their 
aims and expected results. Lack of information about embryo research was reported as one of the 
main reasons to be unwilling to donate embryos for research. Moreover, gaps and misconceptions 
in awareness of cryopreservation were found, and our findings suggest that the patients ought to 
be more fully informed of the facts regarding cryopreservation of embryos, namely the storage 
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periods and the reasons for limitations in these periods. Attention should be drawn to the 
responsibility of scientific and medical institutions, health professionals and researchers regarding 
the provision of accurate and timely information that is attentive, responsive, and tailored to 
patients’ needs, in a context where a decrease in patients’ willingness to donate embryos for 
research over time was observed in our sample. Investment in information provision is especially 
important taking into account that the majority of patients highlighted feelings of trust and 
reciprocity towards the health professionals who contacted with them, as well confidence in the 
medical and scientific institutions. 
In what concerns the contributions of this study to sustain stakeholders’ decisions regarding the 
suitability of research projects using cryopreserved embryos, our data showed that patients who 
were willing to donate embryos for research expected benefits for science, for IVF patients 
through the improvement of ART treatments, and for health in general. In this circumstance, the 
responsibility of health professionals and researchers to communicate realistic expectations 
concerning the results from research on human embryos is highlighted. Additionally, references to 
risks and limitations of research with human embryos should be central topics in the ethics of 
clinical research, care and doctor-patient relationships centred on patients. 
This study also adds important achievements to the development of policies and guidelines 
regarding informed consent practices and decision-making process on embryo donation for 
research. First, by claiming for the inclusion of the subject of decision-making on embryo 
disposition in general guidelines for psychosocial care in infertility and ART, taking into account 
this is an ethically sensitive issue. Second, by showing that psychosocial care in the field of embryo 
donation decision-making should be sensitive to women’s, men’s and couples’ age, religion, trait 
anxiety, and conceptualization of cryopreserved embryos.  
While several studies have found no association between the age of patients and their donation 
decision80, 85, this study showed that younger women were significantly more willing to donate 
embryos for research. This may be related to the perception that younger women have more 
opportunities to become pregnant owing to age-related decline in fertility273, and therefore it 
would not be necessary to transfer the cryopreserved embryos.  
Regarding the psychosocial factors, an anxious state had a significant influence on men’s opinion 
in this study. Higher levels of trait anxiety were found among men who were unwilling to donate 
embryos for research, which can be associated with the fact that individuals with high anxiety 
levels are more likely to avoid perceived threats, especially future events274, in a context where 
158   |   Embryo donation for research: a patient-centred approach 
 
donation of embryos for research can be perceived as a threat. This perception occurs mainly 
when participants report a lack of information about research projects, as previously found83, 216, 
258, or when they have fears about what could happen to their embryos83, 260. Additionally, those 
who were unwilling to donate may feel they did not accomplish the desirable action within a 
context mostly receptive to scientific and technological progress264, which can generate higher 
levels of anxiety. Although no association between donation decision and depression and quality 
of partner relationship was found in this study, further studies should be conducted to validate 
these results. 
This study also contributes to inform socioethical debates about the establishment of storage 
periods and the reasons for limitations in these periods. Quantitative data on patients’ views on 
the embryo storage time limits showed that having experienced at least one previous cycle 
influenced the option for an extended storage limit, while the shortest period was more often 
preferred by female participants with children. These findings suggest that the opinion on the 
embryo storage limit might be influenced by the perception of the probability of using 
cryopreserved embryos for their own treatment – would be parents could see reasons to hold on 
to their cryopreserved embryos as long as possible for maximizing the probability of achieving a 
pregnancy275, while women with children could feel more pressure to use cryopreserved embryos 
in a in a shorter period of time, in line with the belief in the existence of an age range for women 
to conceive276. These features support the need of flexibility and sensitivity in enacting guidelines 
to regulate applications to extend embryo storage, taking into account reproductive trajectories 
and life conditions of patients.  
Additionally, while evidence shows that duration of embryo storage does not interfere with the 
quality of cryopreserved embryos277, 278, patients believed that embryo quality diminishes 
throughout storage, as previously described, grounded on similar metaphors associated with food 
freezing processes217, 279. What this study adds to the literature is the idea that the ‘expiry date’ 
view might be triggered by storage limits, in the sense that patients could construct a parallelism 
between storage limit and embryos’ expiry date, calling attention to the policy and organisational 
aspects that influence shorter period of time, in line with the belief in the existence of an age 
range for women to patients’ experiences207. In a context where participants reported lack of 
knowledge about cryopreservation and embryo storage, the election of evidence-based criteria 
for justifying the establishment of the storage limit (namely financial costs and decreased embryo 
quality) might reveal the search for certainty and objectivity by which patients reinforce trust and 
hope in medicine and technology6, 275. Furthermore, using food metaphors and financial reasoning 
might represent a way by which patients understand and make sense of highly specialized 
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technologies and medical jargon conveyed by empirical knowledge and country’s economic 
situation49, 280. The provision of accurate information regarding policy on embryo storage and the 
development of consensual guidelines regarding storage limit may contribute to raise awareness 
about cryopreservation, both among patients and among health professionals. 
Our data consistently points to the need to improve clinical practices surrounding informed 
consent in order to make them more patient-centred. Patients reported the need of timely 
provision of detailed and intelligible information about the costs and duration of cryopreservation 
and embryo disposition, considering that information about the circumstances under which 
thawing and destruction of embryos may occur, and the ways in which couples can change their 
formalized decisions on the informed consent, is a fundamental right of patients281. This study also 
highlighted the importance of reinforcing physical privacy and having more time to reflect about 
embryo donation for research. The fact that, in some cases, couples’ willingness to donate 
embryos for research changed one year after undergoing their last treatment cycle calls for a 
renewed discussion around the idea of a two/three-stage process to obtain full informed consent, 
as previously suggested80, 87.  
These achievements may help to inform debates on the credence and robustness of informed 
consent given by couples and on the circumstances under which the informed consent should be 
delivered, explained and signed, including the establishment of storage periods and the reasons 
for limitations in these periods, in a context where the views of the patients apply across legal and 
political boundaries. Moreover, it sustains the argument that informed consent should be signed 
only after the infertility treatment is completed, in accordance with the recommendations of the 
Ethics Committee of the American Society for Reproductive Medicine95. 
The challenges identified throughout this thesis were raised by the conceptualization of patient-
centredness on infertility and ART through the lens of public health, and call for a renewed debate 
on embryo donation for research. This approach goes beyond the current assessment of patients’ 
individual experiences and level of satisfaction with care delivery193, 195, while comprising the 
analysis of real circumstances under which decisions on embryo disposition are being made, 
including psychosocial and reproductive factors and structural drivers282, as norms and values 
within society, global and national economic and sociolegal policy, processes of governance at the 
global, national, and local level, as well as the health care system characteristics. 
With the purpose of enriching patient-centredness in embryo donation for research, further work 
needs to be developed around the following issues. First, the meanings attributed by IVF couples 
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to the possibility of visualizing their cryopreserved embryos and how these meanings influence 
decision-making on embryo donation for research. Second, the opinion of IVF patients about 
what should happen when there is no agreement between partners concerning embryo 
disposition. Third, the factors and reasons associated with IVF patients’ willingness to donate 
embryos for other infertile couples, evaluating how this can influence a hierarchisation of the 
possible options regarding embryo disposition. Fourth, the development of comparative studies 
including public and private fertility centres, as well as different cultural settings. 
Additionally, considering that the implementation of patient-centredness includes the 
involvement of clinic staff, their perspectives and experiences also need to be addressed, in order 
to acquire an integrated view about the human and system factors that influence patient-centred 
care. The opinions and experiences of health professionals are essential to understand how 
different forms of organisation, more or less based on the new public management principles, 
might undermine healthcare professionals’ engagement with patient-centred principles.  
This future work would be relevant for the definition of patient-centred policies and regulations 
on decision-making on embryo donation for research, as well as for ethics in clinical practice. It 
would also allow the comparison of the real-world decisions among different cultural, economic 
and political contexts that influence decision-making in embryo disposition. 
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